Page last updated: 2024-08-16

ribavirin and Co-infection

ribavirin has been researched along with Co-infection in 279 studies

Research

Studies (279)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (0.36)	29.6817
2010's	259 (92.83)	24.3611
2020's	19 (6.81)	2.80

Authors

Authors	Studies
Hussain, N; Iqbal, M; Mahnoor, M; Maqsood, Q; Sumrin, A; Wajid, A; Younas, S	1
Ahumada, A; Aldamiz-Echevarría, T; Baliellas, C; Barril, G; Benlloch, S; Bonet, L; Carmona, I; Castaño, MA; Castro, Á; de Álvaro, C; de Los Santos, I; Delgado, M; Devesa-Medina, MJ; García-Buey, L; García-Samaniego, J; Gea-Rodríguez, F; González-Parra, E; Gutiérrez, ML; Jiménez-Pérez, M; Laguno, M; Londoño, MC; Losa, JE; Mallolas, J; Manzanares, A; Martín-Granizo, I; Montero-Alonso, M; Montes, ML; Morán-Sánchez, S; Morano, L; Muñoz-Gómez, R; Navascués, CA; Polo-Lorduy, B; Riveiro-Barciela, M; Rivero, A; Roget, M; Serra, MÁ	1
Carvalho, L; Daniels, E; Eveson, L; Foxton, M; Nelson, M; Pillai, S; Sellers, P; Whyte, R	1
Abdel Alem, S; Abdel Aziz, H; Abdellatif, Z; Al Askalany, M; Cordie, A; El Akel, W; Elsharkawy, A; Esmat, G; Kamal, W; Kamel, S; Kandeel, A; Meshaal, S	1
Bonora, S; Cingolani, A; d'Arminio Monforte, A; Lo Caputo, S; Marinaro, L; Mussini, C; Puoti, M; Rossotti, R; Saracino, A; Soria, A; Tavelli, A; Uberti-Foppa, C	1
Althoff, KN; Elion, RA; Eron, JJ; Gillman, J; Huhn, GD; Jayaweera, DT; Mills, A; Mounzer, K; Moyle, G; Patel, SV; Radtchenko, J; Santiago, S; Sax, PE	1
Alston-Smith, B; Anthony, DD; Balagopal, A; Cohen, DE; Morse, GD; Quinn, J; Santana-Bagur, JL; Smeaton, LM; Sulkowski, MS; Talal, AH; Venuto, CS; Vu, V; Wyles, DL	1
Fan, XG; Ma, SJ; Xiong, YH; Zheng, YX	1
Alston-Smith, BL; Anthony, DD; Balagopal, A; Bhattacharya, D; Cohen, DE; Damjanovska, S; Kowal, CM; Shive, CL; Smeaton, LM; Sulkowski, MS; Wyles, DL	1
Bishburg, E; Nagarakanti, S	1
Liu, CJ; Shih, YF	1
Bellón, JM; Berenguer, J; Carrero, A; Esteban, H; Galindo, MJ; González-García, J; Guardiola, JM; Hernández-Quero, J; Hontañón, V; Jiménez-Sousa, MA; Martínez, E; Navarro, J; Pérez-Latorre, L; Quereda, C; Resino, S; Santos, I; Sanz, J; Téllez, MJ; von Wichmann, MA	1
Aho, I; Amele, S; Bhagani, S; Chkhartisvili, N; Clarke, A; Domingo, P; Falconer, K; Fonquernie, L; Jabłonowska, E; Leen, C; Lundgren, J; Maltez, F; Matulionyte, R; Mocroft, A; Peters, L; Rockstroh, J; Rodger, A; Sarcletti, M; Stephan, C; Szlavik, J; Wandeler, G; Zaccarelli, M; Østergaard, L	1
Ang, TL; Fock, KM; Koh, J; Kumar, LS; Kumar, R; Kwek, A; Law, NM; Lee, ZC; Li, W; Tan, J; Tan, YB; Teo, EK; Thurairajah, PH; Wong, YJ	1
Kamimura, H; Kamimura, K; Terai, S; Tsuchiya, A	1
Aghajani, F; Akhavizadegan, H; Dolatkhani, F; Faghir Gangi, M; Ghasemi, H; Ghazi, Z; Mousavi Movahed, SM; Nejadghaderi, SA	1
Dehghan Manshadi, SA; Kalantari, S; Karimi, J; Malekzadeh, R; Malekzadeh, Z; Mardani, M; Merat, D; Merat, S; Mirminachi, B; Mohraz, M; Nikbin, M; Norouzi, A; Poustchi, H; Rasoolinejad, M; Sali, S; Sedghi, R; Sharifi, AH; Somi, MH; Tabarsi, P; Tayeri, K	1
Bai, L; Chen, L; Du, L; He, M; Kang, S; Li, C; Ma, F; Tang, H	1
Falade-Nwulia, O; Fried, MW; Nelson, DR; Segal, JB; Suarez-Cuervo, C; Sulkowski, MS	1
Adeyemi, O; Bhatti, L; Hu, YB; Khatri, A; King, JR; Lalezari, J; Ruane, P; Saag, M; Shulman, NS; Trinh, R; Viani, RM; Wyles, D	1
Fialho, R; Harrison, N; Pereira, M; Rusted, J; Whale, R	1
Fernández-Cuenca, F; López-Hernández, I; Paniagua-García, M; Ríos-Villegas, MJ	1
Callard, RE; Klein, NJ; Lewis, J; Majekodunmi, AO; Malyuta, R; Thorne, C; Volokha, A	1
Álvarez, B; Benito, JM; Cabello, A; García, M; García-Samaniego, J; Górgolas, M; Madejón, A; Martín-Carbonero, L; Rallón, N	1
Akhavan, S; Calin, R; Demeret, S; Jaspard, M; Katlama, C; Mallet, V; Peytavin, G; Pourcher, V; Poynard, T; Roque-Afonso, AM; Thibault, V; Todesco, E	1
Antón, MD; Ferrando, I; Latorre, P; Moreno Osset, E; Pascual, A; Polanco, A	1
Asim, M; Jamil, A; Majeed, A; Rashid, A; Razak, S; Wahid, M	1
Altice, FL; Barnard, T; Filippovych, S; Mazhnaya, A; Meteliuk, A; Zelenev, A	1
Ballard, C; Cachay, ER; Colwell, B; Hicks, C; Mathews, WC; Torriani, F	1
Cairó, M; Carrion, JA; Cifuentes, C; Crespo, M; Cucurull, J; Erice, E; Force, L; Guardiola, JM; Laguno, M; Marco, A; Navarro, J; Roget, M; Vilaró, J; Vilchez, HH	1
Brown, RS; Camus, G; Copans, A; Ghali, P; Guyer, B; Haubrich, R; Kang, M; Luetkemeyer, AF; Mantry, PS; Ni, L; Rossaro, L; Satapathy, SK; Shen, X; Tam, E	1
Abou-Samra, AB; Butt, AA; Shaikh, OS; Yan, P	1
Apornpong, T; Avihingsanon, A; Burger, DM; Chaiyahong, P; Chittmittraprap, S; Colbers, A; Cuprasitrut, T; de Kanter, CTMM; Khemnark, S; Smolders, EJ; Tangkijvanich, P; Thammajaruk, N	1
Garcia-Broncano, P; Genebat, M; Harrington, S; Hua, S; Leal, M; Lichterfeld, M; Marchetti, G; Negron, J; Resino, S; Ruiz-Mateos, E; Tse, S; Vigano, S; Yu, XG; Zhengyu, O	1
Morikawa, K; Ogawa, K; Sakamoto, N; Suda, G	1
Amador, C; Carmena, J; Flores, J; Galindo, MJ; García-Deltoro, M; Masiá, M; Mínguez, C; Montero, M; Ortega, E; Reus, S	1
Scott, LJ	1
Anderson, PL; Brainard, DM; Bushman, LR; Castillo-Mancilla, JR; Chung, RT; Fierer, DS; Hughes, MD; Kim, AY; Kiser, JJ; MacBrayne, CE; Marks, KM; Naggie, S; Peters, MG; Seifert, SM	1
Berg, CP; Berg, T; Blessin, U; Engelmann, C; Grottenthaler, JM; Harrer, E; Hinterleitner, C; Lauer, UM; Malek, NP; Pathil, A; Sarrazin, C; Scholten, S; Schott, E; Seybold, U; Spengler, U; Steurer, M; Stremmel, W; von Hahn, T; Wedemeyer, H; Welker, MW; Werner, CR	1
Biliotti, E; De Angelis, M; Esvan, R; Franchi, C; Garbuglia, AR; Palazzo, D; Spaziante, M; Taliani, G; Volpicelli, L	1
Sulkowski, MS	3
Bischoff, J; Rockstroh, JK	1
Bair, MJ; Chen, CH; Chen, CK; Chen, CP; Cheng, CH; Cheng, CY; Cheng, SH; Zou, H	1
Asim, M; Khan, A; Rashid, A	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kee, KM; Kuo, FY; Lu, SN; Wang, JH; Yen, YH	1
Cascio, A; Cervo, A; Colomba, C; Di Carlo, P; Firenze, A; Saporito, L; Tolomeo, M; Trizzino, M	1
Angelico, M; Antonucci, F; Armenia, D; Bellocchi, MC; Carioti, L; Ceccherini-Silberstein, F; Cento, V; Ciancio Manuelli, M; De Leonardis, F; Lenci, I; Manzia, TM; Milana, M; Perno, CF; Sforza, D; Sorbo, MC; Tisone, G	1
Wahid, B	2
Chen, J; Li, J; Lu, H; Wang, J; Xiao, H; Yang, F	1
Aldámiz-Echevarría, T; Bellón, JM; Berenguer, J; Carrero, A; Díez, C; Fanciulli, C; Garcia-Broncano, P; Jiménez-Sousa, MA; Medrano, LM; Miralles, P; Pérez-Latorre, L; Resino, S	1
Djauzi, S; Gani, RA; Harimurti, K; Ibrahim, F; Imannuel, S; Kurniawan, J; Nafrialdi, N	1
Bani-Sadr, F; Carrieri, P; Dabis, F; Loko, MA; Marchou, B; Morlat, P; Neau, D; Pambrun, E; Salmon, D; Winnock, M	1
Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY	1
Berg, T; Buggisch, P; Cornberg, M; Deterding, K; Diepolder, H; Feyerabend, S; Galle, PR; Großhennig, A; Grüner, N; Hinrichsen, H; Jung, MC; Koch, A; Lüth, S; Malek, N; Manns, MP; Potthoff, A; Rogalska-Taranta, M; Schlaphoff, V; Spengler, U; Wedemeyer, H; Wiegand, J	1
Cahn, P; Gun, A; Laufer, N; Ojeda, D; Quarleri, J; Sede, M	1
Abeleira, M; Diz, P; Eirea, M; Feijoo, J; Limeres, J; Ocampo, A; Ramos, I	1
Bonnet, F; Hessamfar, M; Michaux, C; Morlat, P; Randrianasolo, D; Vandenhende, MA	1
Abdel-Rahman, M; El Raziky, M; El-Akel, W; El-Sayed, M; Elsharkawy, A; Esmat, G; Ghoneim, H; Khattab, H	1
Chen, PJ; Chu, YT; Kuo, RN; Lai, MS; Liu, CJ; Shau, WY	1
Funk, EK; Heytens, L; Kohli, A; Kottilil, S; Kwan, R; Masur, H; Nelson, A; Polis, MA; Shaffer, A; Shivakumar, B; Sneller, M	1
Branch, AD; Chung, RT; Glesby, MJ; Hollabaugh, K; Kang, M; Wyatt, CM	1
Mendes-Correa, MC; Núñez, M	1
Benito, JM; Berenguer, J; Cosín, J; Fernández-Rodríguez, A; García-Álvarez, M; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; López, JC; Medrano, J; Miralles, P; Rallón, N; Resino, S; Soriano, V	1
Bergin, C; Farrell, G; Gardiner, CM; Keane, C; O'Shea, D; Peck-Radosavljevic, M; Reiberger, T	1
Baumgarten, A; Boesecke, C; Grzeszczuk, A; Mandorfer, M; Meyer-Olson, D; Neukam, K; Payer, BA; Peck-Radosavljevic, M; Pineda, JA; Puoti, M; Reiberger, T; Rivero, A; Rockstroh, JK; Trauner, M; Zangerle, R	1
Battegay, M; Beniowski, M; Grint, D; Jevtovic, D; Kirk, O; Lundgren, JD; Mocroft, A; Peters, L; Pradier, C; Rockstroh, JK; Schwarze-Zander, C; Soriano, V	1
Amendola Pires, MM; Barcaui, HS; Barroso, PF; Brandão-Mello, CE; May, SB; Tavares, GC	1
Aichelburg, MC; Breitenecker, F; Grabmeier-Pfistershammer, K; Mandorfer, M; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Scheiner, B; Trauner, M	1
Aghemo, A; Colombo, M	1
Bichoupan, K; Branch, A; Brinkley, S; Dieterich, D; Martel-Laferrière, V; Perumalswami, P; Posner, S; Schiano, T; Stivala, A; Sulkowski, M	1
Aparicio, E; Clotet, B; Franco, S; Martinez, MA; Parera, M; Tural, C	1
Chiari, E; Cocca, G; Moioli, MC; Morreale, M; Orso, M; Panzeri, C; Puoti, M; Rossotti, R; Travi, G	1
Beste, LA; Green, PK; Ioannou, GN; Scott, JD; Yang, Y	1
Carpio-Pedroza, JC; Cruz-Rivera, M; Escobar-Gutiérrez, A; Fonseca-Coronado, S; Larouche, A; Martinez-Guarneros, A; Ruiz-Tovar, K; Soudeyns, H; Vazquez-Chacon, CA; Yamasaki, LH	1
Kottilil, S; Lee, YJ; Murphy, A; Shivasabesan, G; Siebenlist, U; Suffredini, AF; Vazquez, E; Wang, H; Young, HA; Zhang, X	1
Liu, CJ	1
Bhagani, S; Rockstroh, JK	1
Barluenga, E; Clotet, B; Jou, A; López, JJ; Muga, R; Ojanguren, I; Planas, R; Sanmartín, R; Sanvisens, A; Tor, J; Tural, C; Videla, S	1
Barreiro, P; Camacho, A; Labarga, P; Macias, J; Neukam, K; Pineda, JA; Rivero, A; Rivero-Juarez, A; Soriano, V; Torre-Cisneros, J	1
Berg, RK; Buzon, MJ; Ferrando-Martinez, S; Leal, M; Lichterfeld, M; Ruiz-Mateos, E; Shaw, A; Sun, H; Yu, XG	1
Casado, JL; Martí-Belda, P; Moreno, A; Moreno, S; Pérez-Elías, MJ; Quereda, C	1
Cai, WP; Hu, FY; Lan, Y; Liu, B; Tang, XP; Xu, M	1
Abad-Molina, C; Gutierrez-Valencia, A; Jimenez-Jimenez, L; Lopez-Cortes, LF; Ruiz-Valderas, R; Torres-Cornejo, A; Viciana, P	1
Furusyo, N; Hayashi, J; Hiramine, S; Ikezaki, H; Kainuma, M; Mitsumoto, F; Murata, M; Ogawa, E; Shimizu, M; Takayama, K; Toyoda, K	1
Alvarez, H; de la Llana, FG; Domingo, P; Genebat, M; Guardiola, JM; Hernández-Quero, J; Leal, M; Lluch, JF; Marín, J; Mariño, A; Martínez, L; Martínez-Madrid, O; Martínez-Pérez, MA; Ruiz-Mateos, E; Sánchez-Villegas, J; Vera, F	1
De Biasi, C; Dukan, P; Javelle, E; Lightburne, E; Morand, JJ	1
Aldámiz, T; Benito, JM; Berenguer, J; Fernández-Rodríguez, A; García-Álvarez, M; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; López, JC; Miralles, P; Rallón, N; Resino, S; Restrepo, C; Soriano, V	1
Angarano, G; Bruno, R; Capetti, A; Caputo, A; Cariti, G; Carosi, G; Galli, M; Gulminetti, R; Iannacone, C; Maida, I; Nasta, P; Pontali, E; Puoti, M; Raise, E; Ravasio, V; Verucchi, G	1
Hoshino, T; Kakizaki, S; Koitabashi, E; Kudo, T; Naganuma, A; Okamoto, H; Ryusaki, K; Sakamoto, N; Takagi, H; Uehara, S	1
Bailly, F; Chiarello, P; Gagnieu, MC; Hatu, G; Livrozet, JM; Maynard, M; Miailhes, P; Parant, F; Pourcelot, E; Pradat, P; Zoulim, F	1
Chen, PJ; Liu, CJ	1
Assoumou, SA; Barter, DM; DiLorenzo, M; Freedberg, KA; Horsburgh, CR; Kim, AY; Leff, JA; Linas, BP; Salomon, JA; Schackman, BR; Weinstein, MC	1
Antoine, SL; Mathes, T; Pieper, D	1
Bagnarelli, P; Capobianchi, MR; Ferreri, ML; Galli, C; Garbuglia, AR; Monachetti, A; Sabatini, R	1
Coppola, N; Filippini, P; Martini, S; Pisaturo, M; Sagnelli, C; Sagnelli, E	1
Aichelburg, MC; Boesecke, C; Lang, G; Mandorfer, M; Niederecker, A; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Strassl, R; Trauner, M	1
Cooper, CL; Klein, MB	1
Angeli, E; Caputo, A; Cattelan, AM; Iannacone, C; Maida, I; Nasta, P; Pontali, E; Puoti, M; Verucchi, G	1
James, P; Win, LL; Wong, DK	1
Abdel-Hamid, M; Albert, ML; Bonnard, P; Casrouge, A; Duffy, D; El-Daly, M; Fontanet, A; Hézode, C; Izopet, J; Laird, ME; LeFouler, L; Mallet, V; Mamdouh, R; Mohamed, MK; Mohsen, A; Pawlotsky, JM; Pol, S; Rafik, M; Renard, P; Rosa, I; Soulier, A	1
Camacho, A; Gordon, A; López-Cortés, LF; Pineda, JA; Rivero, A; Rivero-Juarez, A; Ruiz-Valderas, R; Torre-Cisneros, J; Torres-Cornejo, A; Viciana, P	1
Atta, HA; Kamel, M; Kishk, R; Metwally, L; Nemr, N; Ragheb, M	1
Kared, H; Klein, MB; Saeed, S; Shoukry, NH	1
Corchado, S; Girón-González, JA; López-Cortés, LF; Márquez-Coello, M; Rivero, A; Rivero-Juárez, A; Torres-Cornejo, A	1
Bruno, R; Capetti, A; Cariti, G; Galli, M; Iannacone, C; Nasta, P; Palmieri, G; Puoti, M; Raise, E; Ravasio, V	1
Barreiro, P; de Mendoza, C; Fernández-Montero, JV; Labarga, P; Soriano, V	1
Abradelo, M; Agüero, F; Aguilera, V; Antela, A; Barcena, R; Bernal, C; Castells, L; de la Rosa, G; Del Campo, S; Esteban-Mur, JI; Fernandez, JR; González-García, J; Laguno, M; Manzardo, C; Miro, JM; Montero, JL; Olivares, S; Perez, I; Rimola, A; Rodriguez, M; Salcedo, M; Suarez, F; Valdivieso, A; Xiol, X	1
Aboulker, JP; Aumaitre, H; Batisse, D; Bertucci, I; Braun, J; Chevaliez, S; Cotte, L; de Truchis, P; Gervais, A; Lacombe, K; Lascoux-Combe, C; Michelet, C; Molina, JM; Morlat, P; Neau, D; Rosa, I; Sogni, P; Valantin, MA; Vincent, C; Vittecoq, D	1
Rockstroh, JK	1
Aldámiz-Echevarria, T; Berenguer, J; Briz, V; Carrero, A; Diez, C; García-Álvarez, M; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; Pineda-Tenor, D; Resino, S; Tejerina, F	1
Aldámiz-Echevarria, T; Berenguer, J; Briz, V; Carrero, A; Diez, C; García-Álvarez, M; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; Pineda-Tenor, D; Resino, S; Tejerina, F; Vázquez, S	1
Amadasi, S; Castelli, F; Cerini, C; Giralda, M; Nasta, P; Odolini, S	1
Castro, JA; Cifuentes, C; González-Candelas, F; Homar, F; López-Labrador, FX; Matas, M; Moya, A; Payeras, A; Picornell, A; Ramon, C	1
Aldámiz-Echevarria, T; Berenguer, J; Carrero, A; Diez, C; García-Alvarez, M; García-Broncano, P; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; Pineda-Tenor, D; Resino, S; Tejerina, F; Vázquez-Morón, S	1
Bory, F; Broquetas, T; Cabrero, B; Cañete, N; Carrión, JA; Coll, S; García-Retortillo, M; Giménez, MD; González-Colominas, E; Knobel, H; Pellicer, R; Retamero, A; Salas, E; Solà, R	1
Antonini, TM; Bonhomme-Faivre, L; Coilly, A; Duclos-Vallée, JC; Furlan, V; Haim-Boukobza, S; Roque-Afonso, AM; Samuel, D; Sebagh, M; Taburet, AM; Teicher, E; Vittecoq, D	1
Costa e Silva, FV; Jardim, FN; Mosegui, GB; Peregrino, AA; Rodrigues, MP; Vianna, CM	1
Bagaglio, S; Della Torre, L; Hasson, H; Lazzarin, A; Merli, M; Messina, E; Morsica, G; Uberti-Foppa, C	1
Barr, E; Bourliere, M; DeJesus, E; Dutko, F; Gerstoft, J; Haber, B; Hezode, C; Howe, AY; Hwang, P; Kugelmas, M; Mallolas, J; Murillo, A; Nahass, R; Pol, S; Robertson, M; Serfaty, L; Shaughnessy, M; Shibolet, O; Sulkowski, M; Vierling, JM; Wahl, J; Weis, N; Zuckerman, E	1
de los Santos-Gil, I; Haubitz, S; Ingiliz, P; Lutz, T; Márquez, M; Mira, JA; Munteanu, D; Neukam, K; Pineda, JA; Rauch, A; Rivero-Juárez, A; Rockstroh, JK; Scholten, S	1
Beste, LA; Green, PK; Ioannou, GN	1
Chen, TC; Chen, YH; Lin, CY; Lin, SY; Lin, WR; Lu, PL; Yang, YH	1
Modi, R; Saab, S	1
Hunt, SL; Naggie, S; Orkin, C; Puoti, M; Stepanova, M; Sulkowski, M; Younossi, ZM	1
Devaki, P; Jencks, D; McCormack, SA; Nguyen, MH; Nguyen, NH; Vutien, P; Yee, BE	1
Becker, B; Berden, FA; Burger, DM; Colbers, AP; de Kanter, CT; de Knegt, RJ; Dofferhoff, AS; Drenth, JP; Grintjes-Huisman, KJ; Koning, L; Rockstroh, JK; Roukens, MM; Wasmuth, JC	1
Denk, G; Eberle, J; Guba, M; Kaspar, M; Kolligs, F; Pichler, M; Seybold, U; Spannagl, M; Stemberger, M	1
Benschop, KS; Duizer, E; Koopmans, MP; van der Avoort, HG	1
Arends, JE; Dabis, F; Fontaine, H; Gilbert, C; Lacombe, K; Loko, MA; Miailhes, P; Puoti, M; Rockstroh, JK; Rosenthal, E; Salmon, D; Sogni, P; Winnock, M; Wittkop, L	1
Brainard, D; Gaggar, A; Iser, DM; Massetto, B; McHutchison, JG; Molina, JM; Nelson, M; Ni, L; Orkin, C; Puoti, M; Rockstroh, JK; Stephan, C; Subramanian, GM; Svarovskaia, E; Zamora, FX	1
Angeli, E; Caputo, A; Carosi, G; Cattelan, AM; Giralda, M; Iannacone, C; Maida, I; Nasta, P; Pontali, E; Puoti, M; Verucchi, G	1
Angarano, G; Bartolomeo, N; Bruno, G; Fasano, M; Ladisa, N; Maggi, P; Monno, L; Saracino, A; Volpe, A	1
Benito, JM; Berenguer, J; Cosín, J; García-Álvarez, M; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; López, JC; Miralles, P; Pineda-Tenor, D; Rallón, N; Resino, S; Retana, D; Soriano, V	1
Curto, J; Di Yacovo, S; Ferrer, E; Imaz, A; Podzamczer, D; Saumoy, M; Van den Eynde, E; Vila, A	1
Häggblom, A; Nowak, P; Nyström, J; Stenkvist, J; Weiland, O	1
Ben-Marzouk-Hidalgo, OJ; Castillo-Ferrando, JR; Espinosa, N; Gutierrez-Valencia, A; Lopez-Cortes, LF; Ruiz-Valderas, R; Torres-Cornejo, A; Viciana, P	1
Carlsson, T; Hörnfeld, E; Lindahl, K; Parke, Å; Schvarcz, R; Ståhle, L; Weiland, O	1
Brown, A; Habibi, MS; Selvapatt, N	1
Bhagani, S; Collado, A; de Los Santos-Gil, I; Delgado, M; Fehr, J; Haberl, A; López-Cortés, LF; Lutz, T; Mandorfer, M; Márquez, M; Mauss, S; Munteanu, DI; Neukam, K; Pineda, JA; Rivero, A; Rivero-Juárez, A; Rockstroh, JK; Scholten, S; Stoeckle, M	1
Bukowska-Ośko, I; Caraballo Cortés, K; Fic, M; Horban, A; Kaźmierczak, J; Kubisa, N; Laskus, T; Pawełczyk, A; Perlejewski, K; Popiel, M; Płoski, R; Radkowski, M; Rosińska, M; Ząbek, P	1
Agrawal, S; Kwo, PY	1
Chen, TY; Jain, MK	1
Cope, R; Faulds, S; Glowa, T; Pickering, A; Prasad, R; Veldkamp, P	1
Barcan, LA; Gadano, AC; Galdame, OA; Marciano, S	1
Baldelli, S; Cattaneo, D; Gervasoni, C; Milazzo, L; Peri, AM; Rizzardini, G	1
Bruneau, J; Deterding, K; Dore, GJ; Doyle, JS; Grebely, J; Hellard, ME; Kim, AY; Lloyd, AR; Manns, MP; Matthews, G; McGovern, BH; Morris, MD; Page, K; Rice, TM; Sacks-Davis, R; Spelman, T; Wedemeyer, H	1
Burger, DM; de Kanter, CT; Deenen, MJ; Dofferhoff, AS; Drenth, JP; Fleuren, HW; Gisolf, EH; Grintjes-Huisman, KJ; Koopmans, PP; van der Ven, AJ	1
Collado, A; de los Santos-Gil, I; Girón-González, JA; López-Cortés, LF; Macías, J; Merino, D; Mira, JA; Neukam, K; Ojeda-Burgos, G; Pérez-Pérez, M; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Rivero-Juárez, A; Téllez, F; Torres-Cornejo, A	1
Castro-Iglesias, A; Cid, P; Macías, J; Martínez-Marcos, F; Mena, A; Merchante, N; Merino, MD; Monje-Agudo, P; Neukam, K; Ortega-González, E; Pernas, B; Pineda, JA; Real, LM; Rivero, A; Rivero-Juárez, A	1
Anagnostopoulos, A; Aouri, M; Böni, J; Braun, DL; Decosterd, L; Durisch, N; Eberhard, N; Fehr, J; Ledergerber, B; Metzner, KJ; Müllhaupt, B; Rauch, A; Weber, R	1
Chen, DS; Chen, PJ; Kao, JH; Liu, CJ; Tseng, TC	1
Ambrosioni, J; Bernasconi, E; Bregenzer, A; Cavassini, M; Kovari, H; Ledergerber, B; Müller, D; Rauch, A; Rotger, M; Russmann, S; Speck, RF; Stöckle, M; Velli, P	1
Antón, JJ; Caylà, JA; de Juan, J; Faraco, I; Marco, A; Saíz de la Hoya, P; Trujols, J	1
Chung, HK; Lamb, K; Lin, MZ; Plemper, RK; Weisshaar, M; Yan, D	1
Arends, JE; Brinkman, K; Hoepelman, AI; Kortmann, W; Posthouwer, D; Reiss, P; Richter, C; Schinkel, J; Smit, C; van Assen, S; van der Ende, M; van der Meer, JT; van der Valk, M	1
Hirashima, N; Imamura, J; Iwase, H; Shimada, M; Sugiura, W; Watanabe, T; Yokomaku, Y	1
Farfour, E; Hillaire, S; Kahn, JE; Peytavin, G; Sené, T; Zucman, D	1
Ayoub, WS; Lutchman, GA; Nguyen, MH; Nguyen, NH; Yee, BE; Yip, B; Zhang, B	1
Banhegyi, D; Bergin, C; Chernova, O; DeMasi, R; Doroana, M; Gori, A; Hadacek, B; Liu, C; Nelson, M; Rockstroh, JK; Verucchi, G	1
Barrail-Tran, A; Cheret, A; Furlan, V; Molina, JM; Piroth, L; Rosa, I; Rosenthal, E; Taburet, AM; Vincent, C	1
Babudieri, S; Bonfanti, P; Celesia, BM; De Socio, GV; Di Biagio, A; Falasca, K; Maggi, P; Magni, C; Martinelli, C; Menzaghi, B; Nicolini, LA; Parruti, G; Quirino, T; Ricci, E; Salomoni, E; Vichi, F	1
Wyles, DL	1
Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Yeh, ML; Yu, ML	1
Baumgarten, A; Bhagani, S; Boesecke, C; Guiguet, M; Ingiliz, P; Lutz, T; Mauss, S; Nelson, M; Page, E; Reiberger, T; Rockstroh, JK; Stellbrink, HJ; Valantin, MA; Vogel, M; Voigt, E	1
Durant, J; Girard, PM; González-García, J; Grinsztejn, B; Horban, A; Janssen, K; Lathouwers, E; Montes, ML; Nelson, M; Ortega-Gonzalez, E; Ouwerkerk-Mahadevan, S; Rivero, A; Sasadeusz, J; Witek, J; Zakharova, N	1
Azzola, E; Boldrini, A; Bruzzone, B; Cenderello, G; De Leo, P; Di Biagio, A; Grasso, A; Icardi, G; Lorusso, C; Nicolini, LA; Prinapori, R; Rappazzo, E; Sartini, M; Setti, M; Sticchi, L; Valle, C	1
Bedimo, R; Bhattacharya, D; Brown, TT; Evans, C; Hollabaugh, K; Kang, M; McComsey, G; Overton, ET; Taiwo, B; Tebas, P	1
Aldámiz-Echevarria, T; Benito, JM; Berenguer, J; Diez, C; Fernández-Rodríguez, A; García-Álvarez, M; Jiménez-Sousa, MA; Pineda-Tenor, D; Rallón, N; Resino, S; Soriano, V	1
Dollenmaier, G; Krayenbühl, PA; Mani, B; Sahli, R; Schultze, D; Zbinden, A	1
Clark, S; Cooke, GS; Gellissen, R; Irving, W; Main, J; Padam, P; Thomson, E	1
Blanco, J; Clotet, B; Crespo, M; Gómez-Mora, E; Jou, A; Martinez-Picado, J; Montaner, LJ; Morón-López, S; Navarro, J; Ouchi, D; Pérez, M; Puertas, MC; Salgado, M; Tural, C; Urrea, V	1
Bani-Sadr, F; Dabis, F; Gilbert, C; Loko, MA; Morlat, P; Neau, D; Rosenthal, E; Salmon, D; Simon, A; Valantin, MA; Wittkop, L	1
Arends, J; Chene, G; Cosin, J; Dabis, F; Daikos, G; de Wit, S; Mallolas, J; Montforte, Ad; Mussini, C; Peters, L; Raben, D; Rockstroh, J; Smit, C; Zangerle, R; Zinkernagel, A	1
Kohli, A; Kottilil, S; Masur, H; Meissner, EG; Osinusi, A; Remaley, AT; Sampson, M; Sidharthan, S; Tang, L; Townsend, K	1
Chen, DS; Chen, PJ; Hsieh, SM; Hung, CC; Kao, JH; Liu, CH; Liu, CJ; Liu, WC; Lo, YC; Sheng, WH; Su, TH; Sun, HY; Yang, HC	1
Delgado, M; López-Cortés, LF; Macías, J; Ojeda-Burgos, G; Pineda, JA; Recio, E; Ríos, MJ; Rivero-Juárez, A; Téllez, F	1
Busuttil, RW; Cheng, EY; Holt, CD; Saab, S	1
Akamatsu, N; Arita, J; Hasegawa, K; Kaneko, J; Kokudo, N; Maki, H; Sakamoto, Y; Sugawara, Y; Tamura, S; Tanaka, T; Tsukada, K	1
Dore, GJ; Martinello, M	1
Cope, R; Faulds, S; Glowa, T; McMahon, D; Prasad, R	1
Andersohn, F; Claes, AK; Kulp, W; Mahlich, J; Rockstroh, JK	1
Cooke, GS; Hill, A; Riley, RD; Saleem, J; Simmons, B	1
Aldamiz-Echevarria, T; Benito, JM; Berenguer, J; Carrero, A; García-Álvarez, M; Jiménez-Sousa, MA; Pineda-Tenor, D; Rallón, N; Resino, S; Restrepo, C; Soriano, V; Vazquez-Morón, S	1
Ackerman, P; Kalsekar, A; Kelley, C; Mu, F; Peeples, M; Signorovitch, J; Song, J; Swallow, E; Yuan, Y	1
Amorosa, VK; Dou, D; Kang, M; Kottilil, S; Lee, YJ; Matining, R; Osinusi, A; Peters, MG; Petersen, T; Umbleja, T; Wang, C; Zhang, X	1
Camacho, A; Cuenca, F; Frias, M; Gonzalez, R; Gordon, A; Manzanares-Martín, B; Peña, J; Perez-Camacho, I; Pineda, JA; Rivero, A; Rivero-Juarez, A; Rodriguez-Cano, D	1
Cooper, C; Gill, J; Hull, M; Klein, MB; Moqueet, N; Platt, RW	1
Barber, X; Gutiérrez, F; Lidón, F; Masiá, M; Padilla, S; Sanchis, M; Terol, G	1
Poovorawan, K; Poovorawan, Y; Tangkijvanich, P; Thong, VD; Vongpunsawad, S; Wasitthankasem, R	1
Belyakov, NA; Kizlo, SN; Mednikov, RV; Rabinovich, VI; Sokolov, AA	1
Alric, L; Bellissant, E; Bourlière, M; Carrieri, P; Colson, P; Garraffo, R; Ghosn, J; Halfon, P; Molina, JM; Naqvi, A; Piroth, L; Poizot-Martin, I; Renault, A; Solas, C	1
Guo, J; Li, H; Luo, T; Lv, H; Sun, N; Sun, P; Sun, Y; Wang, S; Wang, Z	1
Cai, WP; Chen, XJ; He, Y; Hu, FY; Ke, YC; Lan, Y; Li, LH; Tang, XP	1
Baños, I; Bellot, P; Bhamidimarri, KR; Brainard, DM; Campos-Varela, I; Castells, L; Grewal, P; Guaraldi, G; Hasson, H; McHutchison, JG; Morbey, A; Moreno, A; Terrault, NA	1
Abutidze, A; Bolokadze, N; Chkhartishvili, N; Sharvadze, L; Tsertsvadze, T	1
Barrail-Tran, A; Bellissant, E; Bourlière, M; Cotte, L; Fournier, I; Garraffo, R; Kheloufi, F; Lacarelle, B; Molina, JM; Poizot-Martin, I; Quaranta, S; Renault, A; Solas, C	1
Bocquier, A; Carrieri, MP; Dabis, F; Esterle, L; Marcellin, F; Miailhes, P; Poizot-Martin, I; Protopopescu, C; Salmon-Ceron, D; Spire, B; Wittkop, L	1
Cooper, C; Dieterich, D; Dvory-Sobol, H; Han, L; McHutchison, JG; Naggie, S; Pang, PS; Saag, M; Stamm, LM; Sulkowski, M; Yang, JC	1
Anthony, DD; Butt, AA; Funderburg, NT; Judge, CJ; Kang, M; Landay, AL; Lederman, MM; Sandberg, JK; Sherman, KE	1
Aguilera, A; Arias, A; Benítez-Gutiérrez, L; Cuervas-Mons, V; de Mendoza, C; Lledó, G; Navarro, D; Otero, E; Peña, JM; Soriano, V; Treviño, A	1
Bayer, J; Gardner, EM; Johnson, S; Langness, J; Rogers, M; Rowan, SE; Smith, L	1
Andreis, S; Basso, M; Cattelan, AM; Cavinato, S; Dal Bello, F; Loregian, A; Messa, L; Nannetti, G; Palù, G; Parisi, SG; Scaggiante, R	1
Ceccherini-Silberstein, F; Craxì, A; Perno, CF; Petta, S; Viganò, M	1
Agüero, F; Ambrosioni, J; Costa, J; Forner, A; Laguno, M; Lligoña, A; Londoño, MC; Manzardo, C; Miró, JM; Moreno, A; Rimola, A; Ruiz, P	1
Castelli, F; Di Filippo, E; Di Giambenedetto, S; Di Pietro, M; Fabbiani, M; Focà, E; Gagliardini, R; Gori, A; Maggiolo, F; Pan, A; Postorino, MC; Prosperi, M; Quiros Roldan, E; Saracino, A; Sighinolfi, L; Torti, C	1
De Almeida, PR; De Leon, LB; De Mattos, AA; Feltrin, AA; Kliemann, DA; Pacheco, LS; Tovo, CV	1
Carrero, A; Cervantes, M; Cifuentes, C; Cruceta, A; de Lazzari, E; Deig, E; Gómez-Sirvent, JL; Guardiola, JM; Jou, A; Laguno, M; López-Calvo, S; Mallolas, J; Martínez-Rebollar, M; Montes, ML; Murillas, J; Navarro, J; Pineda, JA; Ruiz-Mesa, JD; Tapiz, A; Van den Eynde, E; Veloso, S; Von Wichmann, MA	1
Ingiliz, P; Jimenez-Exposito, MJ; Peck-Radosavljevic, M; Petersen, J; Rockstroh, JK; Van der Valk, M; Welzel, TM; Zeuzem, S; Zhao, Y	1
But, DY; Chan, CK; Chan, HL; Chan, KH; Fung, J; Hui, YT; Lai, CL; Lai, MS; Lam, YS; Lao, WC; Li, C; Lui, GC; Seto, WK; Tsang, OT; Wong, GL; Wong, VW; Yuen, MF	1
Bräu, N; Dieterich, DT; Miller, TR; Rivera-Mindt, M; Stivala, A; Weiss, JJ	1
Flisiak, R; Flisiak-Jackiewicz, M; Pogorzelska, J	1
Barros, C; Bellón, JM; Berenguer, J; Carrero, A; Crespo, M; Esteban, H; Galindo, MJ; Gaspar, G; González-García, J; Guardiola, JM; Jusdado, JJ; Mallolas, J; Montero, M; Montes, ML; Ortega, E; Pulido, F; Quereda, C; Rodríguez-Castellano, E; Rubio, R; Santos, I; Sanz, J; Téllez, MJ; Tural, C; Von Wichmann, MA	1
Barbati, ZR; Dieterich, DT; El Sayed, A; Fierer, DS; Foster, AL; Morey, T; Turner, SS	1
Backus, LI; Belperio, PS; Bhattacharya, D; Goetz, MB; Loomis, TP; Mole, LA; Shahoumian, TA	1
Ackerman, P; Berenguer, J; Cheinquer, H; Côté, P; Dieterich, D; Eley, T; Fessel, WJ; Gadano, A; Hernandez, D; Hughes, E; Lazzarin, A; Liu, Z; Matthews, G; McPhee, F; Mendez, P; Molina, JM; Moreno, C; Noviello, S; Pineda, JA; Pulido, F; Rivero, A; Rockstroh, J; Sulkowski, MS; Zakharova, N	1
Akremi, R; Allegre, T; Antonini, T; Aumaitre, H; Batisse, D; Bennai, Y; Billaud, E; Chas, J; Dabis, F; De Ledinghen, V; De Truchis, P; Dhiver, C; Dominguez, S; Fedchuk, L; Filipovics, A; Fontaine, H; Harent, S; Lacombe, K; Lafeuillade, A; Leroy, V; Metivier, S; Miailhes, P; Pageaux, GP; Perre, P; Rosenthal, E; Salmon Ceron, D; Sogni, P; Valantin, MA; Zhao, Y	1
Conway, B; Lazzarin, A; Luetkemeyer, A; Molina, JM; Nelson, M; Portsmouth, S; Romanova, S; Rubio, R; Srinivasan, S; Xu, D	1
Casari, S; Castelli, F; Festa, E; Izzo, I; Lanza, P; Odolini, S; Vavassori, A; Zaltron, S	1
Rockstroh, JK; Vogel, M	1
Aydin, I; Ferenci, P; Hofer, H; Mueller, C; Neumueller-Guber, S; Scherzer, TM; Staufer, K; Steindl-Munda, P; Wrba, F	1
Carrieri, MP; Dabis, F; Fugon, L; Lacombe, K; Roux, P; Salmon-Céron, D; Sogni, P; Spire, B; Winnock, M	1
Moreno, V; Valencia, ME	1
Back, D; Dieterich, D; Peters, M; Rockstroh, J; Sherman, KE; Soriano, V; Sulkowski, M	1
Carrieri, MP; Cohen, J; Salmon-Ceron, D; Winnock, M	1
Alvarez, NP; Clotet, B; González, J; Laguno, M; Moltó, J; Ornelas, A; Paredes, R; Sánchez, M; Solà, R; Téllez, MJ; Tural, C; von Wichmann, MÁ; Zamora, AM	1
Bruno, R; Fagiuoli, S; Sacchi, P	1
Chary, A; Holodniy, M	1
Clark, PJ; Thompson, AJ	1
Eslam, M; López-Cortés, LF; Romero-Gomez, M	1
Bergin, C; Dillon, A; Farrell, G; Jackson, A; Kieran, J; Mulcahy, F; Norris, S	1
Boesecke, C; Vogel, M	1
Bhagani, S	1
Chung, RT; Dayyeh, BK; de Bakker, PI; Gupta, N; Sherman, KE	1
Chen, CH; Hu, TH; Huang, CM; Hung, CH; Lee, CM; Lu, SN; Tsai, MC; Wang, JH	1
Emara, MH; Radwan, MI	1
Aberle, J; Ferenci, P; Holzmann, H; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A	1
Alavi, M; Day, C; Dore, GJ; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Van Beek, I; Yeung, B	1
Bergin, C; Hennessy, M; Hopkins, S; Kennedy, A; Mulcahy, F; Spiers, JP	1
Di Martino, V; Kantelip, JP; Monnet, E; Montange, D; Muret, P; Piedoux, S; Piroth, L; Royer, B; Thevenot, T	1
Antinori, S; Foschi, A; Galli, M; Mazzali, C; Milazzo, L; Ridolfo, A; Viola, A	1
Jablonowska, E; Nocun, M; Wojcik, K	1
Clark, PJ; Herrmann, E; Katsounas, A; Kottilil, S; Lempicki, R; Masur, H; McHutchison, JG; Muir, AJ; Naggie, S; Osinusi, A; Patel, K; Polis, MA; Schlaak, JF; Shivakumar, B; Thompson, AJ; Trippler, M	1
Bai, F; Bellistrì, GM; Borghi, F; Carosi, G; Gatti, F; Marchetti, G; Monforte, Ad; Nasta, P; Puoti, M; Tincati, C	1
Naggie, S; Sulkowski, MS	1
Applegate, T; Dore, GJ; Feld, JJ; George, J; Grebely, J; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Rawlinson, W; Yeung, B	1
Andersen, JW; Butt, AA; Chung, RT; Sherman, KE; Umbleja, T	1
Bani-Sadr, F; Cacoub, P; Carrat, F; Fromentin, D; Krastinova, E; Perronne, C; Piroth, L; Pol, S; Quertainmont, Y; Rosenthal, E	1
Fishbein, D; Funk, E; Hu, Z; Kottilil, S; Masur, H; Naggie, S; Osinusi, A; Polis, M; Poonia, S; Schlaak, J; Trippler, M	1
Igarashi, T; Inoue, J; Kakazu, E; Kimura, O; Kobayashi, K; Kobayashi, T; Kondo, Y; Miura, M; Ninomiya, M; Shimosegawa, T; Tamai, K; Tanaka, Y; Ueno, Y; Yamamoto, T	1
Barros, C; Bellón, JM; Berenguer, J; Esteban, H; Galindo, MJ; Gaspar, G; González-García, J; Guardiola, JM; Jou, A; Jusdado, JJ; López-Aldeguer, J; Mallolas, J; Miralles, P; Montes, ML; Ortega, E; Pulido, F; Quereda, C; Rodríguez, E; Rubio, R; Santos, I; Sanz, J; Téllez, MJ; Van Den Eynde, E; Von Wichmann, MA	1
Amin, J; Dore, GJ; George, J; Gidding, HF; Haber, PA; Law, MG; Macdonald, GA; Ostapowicz, G; Sasadeusz, JJ; Weltman, M	1
de Los Santos-Gil, I; del Mar Viloria, M; Girón-González, JA; López-Cortés, LF; Macías, J; Márquez, M; Merino, D; Mira, JA; Omar, M; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Rivero-Juárez, A; Téllez, F	1
Bailly, F; Zoulim, F	1
Barreiro, P; Benito, JM; Labarga, P; Rallon, NI; Soriano, V; Vispo, E	1
Boesecke, C; Rockstroh, JK	1
Bani-Sadr, F; Dominguez, S; Garraffo, R; Izopet, J; Pambrun, E; Peytavin, G; Poizot-Martin, I; Salmon, D; Solas, C; Winnock, M	1
Anthony, DD; Blanton, RE; Conry, SJ; Falck-Ytter, Y; Landay, AL; Lederman, MM; Medvik, K; Rodriguez, B; Sandberg, JK; Sandhya Rani, MR	1
Amorosa, VK; Gross, R; Kaplan, DE; Lo Re, V; Localio, AR; Teal, V	1
Jabłonowska, E; Koślińska-Berkan, E; Omulecka, A; Piekarska, A; Szymańska, B; Wójcik, K	1
Aichelburg, MC; Breitenecker, F; Ferlitsch, A; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Schmied, B; Sieghart, W; Trauner, M	1
Clotet, B; Franco, S; Martinez, MA; Tural, C	1
Andersen, JW; Butt, AA; Chung, RT; Hua, L; Kemmer, N; Sherman, KE	1
Alves, AL; Augusto, F; Cardoso, C; Freire, R; Gonçalves, M; Oliveira, AP; Quintana, C	1
Asensi, V; Cartón, JA; Collazos, J; de la Fuente, B	1
Camacho, A; Caruz, A; Macias, J; Mira, JA; Neukam, K; Perez-Camacho, I; Pineda, JA; Rivero, A; Rivero-Juarez, A; Torre-Cisneros, J	1
Bárcena, R; Casado, JL; Del Campo, S; Dronda, F; Mateos, ML; Montes, M; Moreno, A; Moreno, S; Pérez-Elías, MJ; Quereda, C; Rodríguez-Sagrado, MA	1
Benito, JM; Berenguer, J; Cosín, J; Fernández-Rodríguez, A; García-Álvarez, M; Guzmán-Fulgencio, M; Jiménez-Sousa, MA; Lopez, JC; Miralles, P; Rallón, N; Resino, S; Restrepo, C; Soriano, V	1
Camacho, A; Caruz, A; Gutierrez-Valencia, A; Lopez-Cortes, LF; Marquez-Solero, M; Pineda, JA; Rivero, A; Rivero-Juárez, A; Ruiz-Valderas, R; Torre-Cisneros, J; Torres-Cornejo, A	1
Driver, TH; Saxena, V; Terrault, N	1
Kwo, PY	1
Benguria, A; Benito, JM; Fiorante, S; Garcia, MI; Lopez-Fernandez, LA; Rallon, NI; Soriano, V	1
Aichelburg, MC; Breitenecker, F; Ferlitsch, A; Mandorfer, M; Obermayer-Pietsch, B; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Trauner, M	1
Chao, YC; Chen, CL; Chen, DS; Chen, PJ; Chuang, WL; Kao, JH; Kuo, HT; Lee, CM; Liao, LY; Lin, CL; Liu, CH; Liu, CJ; Lu, SN; Su, WW; Tung, SY; Wu, SS; Yang, HC; Yang, SS; Yu, ML	1
Sönnerborg, A; Stenkvist, J; Weiland, O	1
Alvarez-Pellicer, J; Barquilla, E; Barros, C; Bellón, JM; Berenguer, J; Carrero, A; Galindo, MJ; Gaspar, G; González-García, J; Guardiola, JM; Jusdado, JJ; López-Aldeguer, J; Mallolas, J; Montes, ML; Ortega, E; Pulido, F; Quereda, C; Rubio, R; Santos, I; Sanz, J; Téllez, MJ; Tural, C; Van Den Eynde, E; Von Wichmann, MA	1

Reviews

38 review(s) available for ribavirin and Co-infection

Article	Year
Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives. Antiviral therapy, 2023, Volume: 28, Issue:4 Topics: Antiviral Agents; Coinfection; Hepacivirus; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Ribavirin	2023
Efficacy and safety of direct acting antiviral regimens for hepatitis C virus and human immunodeficiency virus co-infection: systematic review and network meta-analysis. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:9 Topics: Administration, Oral; Adult; Aged; Amides; Antiviral Agents; Benzofurans; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Quinoxalines; Ribavirin; Safety; Sulfonamides; Sustained Virologic Response; Treatment Outcome	2020
Hepatitis C Virus and Hepatitis B Virus Co-Infection. Viruses, 2020, 07-10, Volume: 12, Issue:7 Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Coinfection; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Interferons; Mice; Microbial Interactions; Ribavirin; Risk Factors; Virus Activation; Virus Replication	2020
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. Annals of internal medicine, 2017, May-02, Volume: 166, Issue:9 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Liver Cirrhosis; Liver Transplantation; Renal Insufficiency, Chronic; Ribavirin	2017
Treatment of hepatitis C in special populations. Journal of gastroenterology, 2018, Volume: 53, Issue:5 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Immunocompromised Host; Interferons; Liver Transplantation; Postoperative Period; Protease Inhibitors; Recurrence; Renal Dialysis; Renal Insufficiency, Chronic; Ribavirin	2018
Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C. Drugs, 2018, Volume: 78, Issue:2 Topics: Antiviral Agents; Benzimidazoles; Coinfection; Drug Combinations; Drug Therapy, Combination; Fluorenes; Genotype; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Ribavirin; Sofosbuvir; Treatment Outcome; Uridine Monophosphate	2018
Are there any challenges left in hepatitis C virus therapy of HIV-infected patients? International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzimidazoles; Carbamates; Coinfection; Drug Interactions; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sexual and Gender Minorities; Sofosbuvir; Sustained Virologic Response; Treatment Outcome	2020
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. Transplantation proceedings, 2013, Volume: 45, Issue:2 Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Recurrence; Ribavirin; Time Factors; Treatment Outcome	2013
Viral hepatitis and HIV: update and management. Antiviral therapy, 2013, Volume: 18, Issue:3 Pt B Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Therapy, Combination; Guanine; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Organophosphonates; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Tenofovir	2013
Optimizing treatment in HIV/HCV coinfection. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Sep-30, Volume: 45 Suppl 5 Topics: Anti-Retroviral Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Oligopeptides; Proline; Ribavirin	2013
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:1 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Virus Activation	2014
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals. BMC medicine, 2013, Nov-01, Volume: 11 Topics: Antiviral Agents; Coinfection; Hepatitis C; HIV Infections; Humans; Interferons; Ribavirin	2013
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection. World journal of gastroenterology, 2014, Mar-21, Volume: 20, Issue:11 Topics: Antiviral Agents; Coinfection; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Ribavirin; Treatment Outcome	2014
Factors influencing adherence in Hepatitis-C infected patients: a systematic review. BMC infectious diseases, 2014, Apr-15, Volume: 14 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Humans; Medication Adherence; Polyethylene Glycols; Ribavirin	2014
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10 Topics: Adenine; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Organophosphonates; Ribavirin; RNA, Viral; Tenofovir; Virus Replication	2014
Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirin. Intervirology, 2015, Volume: 58, Issue:1 Topics: Adult; Antiviral Agents; Asian People; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome	2015
Antivirals against enteroviruses: a critical review from a public-health perspective. Antiviral therapy, 2015, Volume: 20, Issue:2 Topics: Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Coinfection; Drug Resistance, Viral; Enterovirus; Enterovirus Infections; Epidemiological Monitoring; Hepatitis C; Humans; Immunocompromised Host; Influenza, Human; Public Health; Ribavirin	2015
Perspectives on dual hepatitis B and C infection in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:5 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Taiwan; Treatment Outcome	2016
Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. Intervirology, 2015, Volume: 58, Issue:4 Topics: Acute Disease; Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepatitis C; HIV Infections; HIV Seropositivity; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral	2015
Regimens for Patients Coinfected with Human Immunodeficiency Virus. Clinics in liver disease, 2015, Volume: 19, Issue:4 Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferons; Nucleic Acid Synthesis Inhibitors; Polyethylene Glycols; Protease Inhibitors; Ribavirin; RNA, Viral; Sofosbuvir; Viral Nonstructural Proteins	2015
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison. BMC infectious diseases, 2016, Jan-11, Volume: 16 Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Simeprevir; Treatment Outcome	2016
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Mar-15, Volume: 62, Issue:6 Topics: Adolescent; Adult; Antiviral Agents; Coinfection; Drug Users; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Male; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Sustained Virologic Response; Viral Load; Young Adult	2016
Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison. Clinical therapeutics, 2016, Volume: 38, Issue:2 Topics: Antiviral Agents; Carbamates; Clinical Trials, Phase III as Topic; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Valine	2016
Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis. Intervirology, 2015, Volume: 58, Issue:6 Topics: Antiviral Agents; Coinfection; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon-alpha; Polyethylene Glycols; Polymorphism, Genetic; Ribavirin; Treatment Outcome	2015
Hepatitis C: efficacy and safety in real life. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37 Suppl 1 Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Pyrrolidines; Ribavirin; Risk Factors; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine	2017
The treatment of chronic hepatitis C virus infection in HIV co-infection. European journal of medical research, 2009, Volume: 14 Topics: Antiretroviral Therapy, Highly Active; Coinfection; Europe; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Ribavirin	2009
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS (London, England), 2011, Nov-28, Volume: 25, Issue:18 Topics: Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Coinfection; Drug Resistance, Viral; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin	2011
Interferon combination therapy for HIV/hepatitis C virus coinfection. Immunotherapy, 2011, Volume: 3, Issue:9 Topics: Coinfection; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2011
Host genomics and HCV treatment response. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2 Topics: Animals; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genome-Wide Association Study; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Phenotype; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recurrence; Ribavirin; Treatment Outcome	2012
The role of insulin resistance in HIV/hepatitis C virus-coinfected patients. Current opinion in HIV and AIDS, 2011, Volume: 6, Issue:6 Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Clinical Trials as Topic; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Insulin Resistance; Interferon-alpha; Polyethylene Glycols; Ribavirin; RNA, Viral; Treatment Outcome	2011
HIV and hepatitis C co-infection: acute HCV therapy. Current opinion in HIV and AIDS, 2011, Volume: 6, Issue:6 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Homosexuality, Male; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2011
Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin. Current opinion in HIV and AIDS, 2011, Volume: 6, Issue:6 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Multicenter Studies as Topic; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load	2011
Hepatitis C virus-human immunodeficiency virus coinfection. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1 Topics: Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Oligopeptides; Patient Selection; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Treatment Failure; Treatment Outcome; Viral Load	2012
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology, 2012, Volume: 142, Issue:6 Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome	2012
Acute hepatitis C in patients with HIV. Seminars in liver disease, 2012, Volume: 32, Issue:2 Topics: Antiviral Agents; Australia; Coinfection; Europe; Female; Hepatitis C; HIV Infections; Humans; Interferons; Male; Ribavirin; United States	2012
Acute hepatitis C in an HIV-infected patient: a case report and review of literature. Journal of general internal medicine, 2013, Volume: 28, Issue:5 Topics: Acute Disease; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Homosexuality; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load	2013
Boceprevir and treatment of chronic hepatitis C. Clinics in liver disease, 2013, Volume: 17, Issue:1 Topics: Anemia; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors	2013
HCV therapy in HIV-infected patients. Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33 Suppl 1 Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Treatment Outcome; Viral Nonstructural Proteins	2013

Trials

38 trial(s) available for ribavirin and Co-infection

Article	Year
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy. The Journal of infectious diseases, 2020, 07-23, Volume: 222, Issue:4 Topics: 2-Naphthylamine; Acquired Immunodeficiency Syndrome; Adult; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Female; Hepatitis C, Chronic; Humans; Kinetics; Lactams, Macrocyclic; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; United States; Uracil; Valine; Viral Load	2020
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. The Journal of infectious diseases, 2020, 09-14, Volume: 222, Issue:8 Topics: 2-Naphthylamine; Adult; Anilides; Anti-HIV Agents; Antiviral Agents; Biomarkers; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Immunologic Factors; Lactams, Macrocyclic; Liver Cirrhosis; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine	2020
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir. The Journal of infectious diseases, 2017, 02-15, Volume: 215, Issue:4 Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Anilides; Anti-Retroviral Agents; Body Mass Index; Carbamates; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Darunavir; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV-1; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine; Young Adult	2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:6 Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Fatigue; Female; Fluorenes; Headache; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Pregnancy; Ribavirin; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate	2018
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. The Journal of antimicrobial chemotherapy, 2018, 08-01, Volume: 73, Issue:8 Topics: Adenine; Adult; Antiviral Agents; Benzimidazoles; Coinfection; Drug Interactions; Fluorenes; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Organophosphates; Ribavirin; Sofosbuvir; Tenofovir; Uridine Monophosphate	2018
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial. The Lancet. Infectious diseases, 2013, Volume: 13, Issue:6 Topics: Acute Disease; Adult; Aged; Antiviral Agents; Coinfection; Drug Administration Schedule; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Young Adult	2013
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS (London, England), 2014, Jan-28, Volume: 28, Issue:3 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Cost-Benefit Analysis; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Oligopeptides; Ribavirin; Treatment Outcome; United States	2014
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. Antiviral therapy, 2015, Volume: 20, Issue:1 Topics: Adult; Anemia; Antiviral Agents; Cell Count; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Viral Load	2015
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:1 Topics: Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Italy; Odds Ratio; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral	2015
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Dec-15, Volume: 59, Issue:12 Topics: Antiviral Agents; Coinfection; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2014
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a rando Lancet (London, England), 2015, Mar-21, Volume: 385, Issue:9973 Topics: Adult; Aged; Amides; Antiviral Agents; Benzofurans; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Quinoxalines; Ribavirin; RNA, Viral; Sulfonamides; Treatment Outcome; Viral Load; Young Adult	2015
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes. The Journal of infectious diseases, 2015, Aug-01, Volume: 212, Issue:3 Topics: Antiviral Agents; Coinfection; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Quality of Life; Ribavirin; Self Report; Sofosbuvir; Treatment Outcome; Uridine Monophosphate	2015
The ARRIBA concept: adequate resorption of ribavirin. Antiviral therapy, 2015, Volume: 20, Issue:5 Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Coinfection; Dose-Response Relationship, Drug; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Lancet (London, England), 2015, Mar-21, Volume: 385, Issue:9973 Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; RNA, Viral; Sofosbuvir; Treatment Outcome; Uridine Monophosphate; Viral Load; Young Adult	2015
Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR. The new microbiologica, 2015, Volume: 38, Issue:1 Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2015
Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6 Topics: Adult; Antiviral Agents; Coinfection; Creatinine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Ribavirin; Tandem Mass Spectrometry	2015
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients. PloS one, 2015, Volume: 10, Issue:7 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Patient Safety; Polyethylene Glycols; Prospective Studies; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load	2015
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme. The Journal of infection, 2015, Volume: 71, Issue:6 Topics: Adolescent; Adult; Aged; Antiviral Agents; Bilirubin; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Oligopeptides; Ribavirin; RNA, Viral; Young Adult	2015
Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult	2016
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients. AIDS research and human retroviruses, 2016, Volume: 32, Issue:4 Topics: Adult; Antiviral Agents; Biomarkers; Bone Remodeling; Coinfection; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome	2016
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration. AIDS research and human retroviruses, 2016, Volume: 32, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Cardiovascular Diseases; Cholesterol, LDL; Coinfection; Drug Therapy, Combination; Dyslipidemias; Female; Fluorenes; Furans; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Quinolines; Ribavirin; Sofosbuvir; Thiophenes; Uridine Monophosphate	2016
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. PloS one, 2015, Volume: 10, Issue:12 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Nitro Compounds; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thiazoles; Treatment Outcome	2015
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. AIDS research and human retroviruses, 2016, Volume: 32, Issue:7 Topics: Adult; Antiviral Agents; Coinfection; Female; Gene Expression Profiling; Hepatitis C, Chronic; HIV Infections; Humans; Immunologic Factors; Interferon-alpha; Interferons; Leukocytes, Mononuclear; Male; Middle Aged; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiazoles	2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. HIV clinical trials, 2016, Volume: 17, Issue:2 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Treatment Outcome	2016
Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. Journal of acquired immune deficiency syndromes (1999), 2016, 11-01, Volume: 73, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; CD4-Positive T-Lymphocytes; Coinfection; Female; Hepacivirus; HIV Infections; Humans; Immunologic Memory; Interferons; Lipopolysaccharide Receptors; Lymphocyte Activation; Male; Middle Aged; Monocytes; Ribavirin; Young Adult	2016
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 53 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Proline; Prospective Studies; Recombinant Proteins; Retreatment; Ribavirin; Spain; Treatment Outcome; Viral Nonstructural Proteins	2016
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study. Hepatology international, 2017, Volume: 11, Issue:2 Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Ribavirin; Treatment Outcome; Valine; Young Adult	2017
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2017, Volume: 37, Issue:3 Topics: Adult; Aged; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Interferons; Male; Middle Aged; Pyrrolidines; Ribavirin; Treatment Outcome; Valine; Viral Load	2017
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study. Antiviral therapy, 2011, Volume: 16, Issue:6 Topics: Adult; Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load	2011
IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. PloS one, 2011, Volume: 6, Issue:10 Topics: Alleles; Cohort Studies; Coinfection; Drug Synergism; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Probability; Recombinant Proteins; Ribavirin; Treatment Outcome	2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:5 Topics: Adult; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Drug Users; Employment; Female; Hepatitis C; HIV Seropositivity; Humans; Interferon-alpha; Logistic Models; Male; Mental Health; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Participation; Substance Abuse, Intravenous; Surveys and Questionnaires; Viral Load; Young Adult	2012
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response. Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:2 Topics: Adult; Albumins; Antiviral Agents; Cohort Studies; Coinfection; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunity, Innate; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Middle Aged; Pharmacogenetics; Polyethylene Glycols; Polymorphism, Single Nucleotide; Prospective Studies; Recombinant Proteins; Ribavirin	2012
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:5 Topics: Adult; Analysis of Variance; Antiviral Agents; Coinfection; Female; Hepatitis C; HIV Infections; Humans; Insulin Resistance; Interferon-alpha; Lipid Metabolism; Lipoproteins; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Ribavirin	2012
Hepatitis C treatment outcomes in Australian clinics. The Medical journal of Australia, 2012, Jun-04, Volume: 196, Issue:10 Topics: Adult; Antiviral Agents; Australia; Body Mass Index; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome	2012
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection. The Journal of infectious diseases, 2012, Sep-15, Volume: 206, Issue:6 Topics: Adult; Antiviral Agents; CD56 Antigen; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Killer Cells, Natural; Lipopolysaccharide Receptors; Male; Polyethylene Glycols; Receptors, IgG; Recombinant Proteins; Ribavirin	2012
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. Journal of viral hepatitis, 2012, Volume: 19, Issue:11 Topics: Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Treatment Outcome	2012
Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir. Journal of acquired immune deficiency syndromes (1999), 2012, Nov-01, Volume: 61, Issue:3 Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin	2012
Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients. PloS one, 2012, Volume: 7, Issue:11 Topics: Adult; Antiviral Agents; Coinfection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load	2012

Other Studies

203 other study(ies) available for ribavirin and Co-infection

Article	Year
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study. PloS one, 2019, Volume: 14, Issue:9 Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Ribavirin; Ritonavir; Spain; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine	2019
Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience. The Journal of infection, 2020, Volume: 80, Issue:2 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Retrospective Studies; Ribavirin; Treatment Outcome	2020
Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020, 04-08, Volume: 114, Issue:4 Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine	2020
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2020, Volume: 52, Issue:4 Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Italy; Male; Middle Aged; Pyrrolidines; Regression Analysis; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine	2020
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV. PloS one, 2020, Volume: 15, Issue:2 Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Coinfection; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; United States; Uridine Monophosphate; Viral Load	2020
Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS. The American journal of case reports, 2020, Jul-11, Volume: 21 Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antiviral Agents; Ceftriaxone; Coinfection; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Paramyxoviridae Infections; Pneumonia, Viral; Respiration, Artificial; Respiratory Distress Syndrome; Ribavirin	2020
Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7 Topics: Antiviral Agents; Bone Density; Coinfection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2021
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study. Journal of acquired immune deficiency syndromes (1999), 2021, 02-01, Volume: 86, Issue:2 Topics: Anilides; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Female; Fluorenes; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Lactams, Macrocyclic; Male; Middle Aged; Proline; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine	2021
Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort. Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:5 Topics: Adult; Carbamates; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome	2021
Successful treatment of positive-sense RNA virus coinfection with autoimmune hepatitis using double filtration plasmapheresis. BMJ case reports, 2021, Mar-25, Volume: 14, Issue:3 Topics: Antiviral Agents; Coinfection; COVID-19; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Interferon alpha-2; Middle Aged; Plasmapheresis; Polyethylene Glycols; Positive-Strand RNA Viruses; Ribavirin; SARS-CoV-2; Treatment Outcome; Viral Load	2021
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study. Journal of medical virology, 2021, Volume: 93, Issue:7 Topics: Acute Kidney Injury; Adult; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Female; Hospital Mortality; Hospitalization; Humans; Iran; Linezolid; Lopinavir; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome; Vancomycin	2021
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus. International journal of clinical practice, 2021, Volume: 75, Issue:8 Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine	2021
Sofosbuvir plus Ribavirin is effective for HCV elimination in people living with HIV from rural area of China. Scientific reports, 2021, 05-28, Volume: 11, Issue:1 Topics: Adult; Antiviral Agents; China; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Male; Ribavirin; Rural Population; Sofosbuvir; Sustained Virologic Response	2021
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry research, 2017, Volume: 253 Topics: Adult; Antiviral Agents; Coinfection; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Ribavirin	2017
Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV. Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:10 Topics: Anti-HIV Agents; Antiviral Agents; Benzimidazoles; Coinfection; Drug Substitution; Fatal Outcome; Fluorenes; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Liver Failure, Acute; Male; Middle Aged; Oligopeptides; Ribavirin; Sofosbuvir; Virus Activation	2017
Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy. The Pediatric infectious disease journal, 2017, Volume: 36, Issue:5 Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Cohort Studies; Coinfection; Drug Combinations; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Lamivudine; Lopinavir; Male; Models, Immunological; Polyethylene Glycols; Recombinant Proteins; Recovery of Function; Ribavirin; Ritonavir; Time-to-Treatment; Zidovudine	2017
Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2017, Volume: 37, Issue:6 Topics: Adaptive Immunity; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Coinfection; Female; Gene Expression Regulation; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Immunity, Innate; Interferon-alpha; Interferons; Interleukins; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2017
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin. AIDS (London, England), 2017, 06-01, Volume: 31, Issue:9 Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Hepatitis B; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure; Viral Load	2017
Hepatitis B reactivation in a patient with chronic hepatitis C treated with direct-acting antivirals. Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:5 Topics: Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Protease Inhibitors; Ribavirin; Ritonavir; Sulfonamides; Valine; Viral Load; Viral Nonstructural Proteins; Viremia; Virus Activation	2018
Association of Interferon Alpha Receptor 1 with sustained virological response in hepatitis C and B co-infected patients. JPMA. The Journal of the Pakistan Medical Association, 2017, Volume: 67, Issue:7 Topics: Adult; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Polyethylene Glycols; Prognosis; Receptor, Interferon alpha-beta; Recombinant Proteins; Ribavirin; RNA, Messenger; RNA, Viral; Sustained Virologic Response	2017
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes. The International journal on drug policy, 2017, Volume: 47 Topics: Adult; Antiviral Agents; Coinfection; Female; Genotype; Health Services; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Polyethylene Glycols; Program Development; Program Evaluation; Recombinant Proteins; Ribavirin; Risk Factors; Sex Factors; Sofosbuvir; Substance Abuse, Intravenous; Sustained Virologic Response; Treatment Outcome; Ukraine; Young Adult	2017
Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment. AIDS research and therapy, 2017, Sep-20, Volume: 14, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Retrospective Studies; Ribavirin; Surveys and Questionnaires; Treatment Outcome	2017
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients. The Journal of antimicrobial chemotherapy, 2017, 10-01, Volume: 72, Issue:10 Topics: Antiviral Agents; Benzimidazoles; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Spain; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate	2017
Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:3 Topics: Aged; Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Virus Activation	2018
Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics. Tropical medicine & international health : TM & IH, 2018, Volume: 23, Issue:3 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Ribavirin; Thailand; Treatment Outcome; Viral Load	2018
Pegylated Interferon-α-Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy-Treated HIV-1/Hepatitis C Virus-Coinfected Patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 06-01, Volume: 66, Issue:12 Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; Disease Reservoirs; DNA, Viral; Female; gag Gene Products, Human Immunodeficiency Virus; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Killer Cells, Natural; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Spain; Viral Load	2018
Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients. AIDS (London, England), 2018, 01-28, Volume: 32, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiviral Agents; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Ribavirin; Spain; Treatment Outcome; Young Adult	2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation. PloS one, 2018, Volume: 13, Issue:6 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Germany; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Ribavirin; Ritonavir; Sofosbuvir; Treatment Outcome	2018
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin. Infection, 2018, Volume: 46, Issue:5 Topics: Acute-On-Chronic Liver Failure; Biomarkers; Coinfection; Drug Therapy, Combination; Fatal Outcome; Hepatitis E; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Shock, Septic; Sofosbuvir; Treatment Outcome; Viral Load	2018
The Proof Is in the Patient: Hepatitis C Virus Microelimination in the Swiss Human Immunodeficiency Virus Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 02-01, Volume: 68, Issue:4 Topics: Amides; Benzofurans; Carbamates; Cohort Studies; Coinfection; Cyclopropanes; Hepacivirus; HIV; HIV Infections; Homosexuality, Male; Humans; Imidazoles; Male; Quinoxalines; Ribavirin; Sexual and Gender Minorities; Sulfonamides	2019
Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:4 Topics: Adult; Antiviral Agents; Coinfection; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Genotype; Health Care Costs; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Prisons; Retrospective Studies; Ribavirin; Taiwan; Viral Load	2019
Interferon alpha receptors and STAT1 as therapy predictors of a sustained virological response in hepatitis C/B co-infection. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:11 Topics: Adult; Antibodies, Viral; Coinfection; Cross-Sectional Studies; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Polymerase Chain Reaction; Receptor, Interferon alpha-beta; Recombinant Proteins; Retrospective Studies; Ribavirin; STAT1 Transcription Factor	2018
A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort. Medicine, 2018, Volume: 97, Issue:50 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis C; Humans; Interferons; Male; Metabolic Clearance Rate; Middle Aged; Research Design; Retrospective Studies; Ribavirin; ROC Curve	2018
Direct-acting antivirals and visceral leishmaniasis: a case report. BMC infectious diseases, 2019, Apr-18, Volume: 19, Issue:1 Topics: Aged; Amphotericin B; Antiprotozoal Agents; Antiviral Agents; Coinfection; Hepatitis C, Chronic; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Ribavirin; Sofosbuvir	2019
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:10 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Phylogeny; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Failure; Viral Nonstructural Proteins	2019
Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report. Journal of infection and public health, 2020, Volume: 13, Issue:1 Topics: Aged; Antiviral Agents; Asthma; Carbamates; Coinfection; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; Hepatitis E; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tenofovir; Treatment Outcome; Valine; Viral Load	2020
Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patients previously treated for tuberculosis. Journal of medical virology, 2019, Volume: 91, Issue:12 Topics: Aged; Antitubercular Agents; Antiviral Agents; Carbamates; Chemical and Drug Induced Liver Injury; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tuberculosis; Valine	2019
Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection. Medicine, 2019, Volume: 98, Issue:30 Topics: Adult; Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Imidazoles; Interferons; Isoquinolines; Male; Middle Aged; Pyrrolidines; Retrospective Studies; Ribavirin; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine	2019
European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study. Journal of translational medicine, 2019, 07-26, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Coinfection; Disease Progression; DNA, Mitochondrial; Europe; Female; Genotype; Haplotypes; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Liver Failure; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk	2019
The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study. Acta medica Indonesiana, 2019, Volume: 51, Issue:2 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Interferons; Male; Middle Aged; Mutation; Polyethylene Glycols; Polymorphism, Single Nucleotide; Prospective Studies; Ribavirin; Sustained Virologic Response; Viral Nonstructural Proteins	2019
Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. HIV medicine, 2013, Volume: 14, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antiviral Agents; Cardiovascular Diseases; Coinfection; Comorbidity; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Practice Guidelines as Topic; Ribavirin; Young Adult	2013
Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin. Archives of virology, 2013, Volume: 158, Issue:9 Topics: Amino Acid Sequence; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Molecular Sequence Data; Nitro Compounds; Polyethylene Glycols; Ribavirin; Sequence Alignment; Sequence Analysis, DNA; Thiazoles; Treatment Failure; Viral Nonstructural Proteins	2013
HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin. Oral diseases, 2014, Volume: 20, Issue:3 Topics: Adult; Aged; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Saliva; Viral Load	2014
[Thrombotic thrombocytopenic purpura associated with interferon therapy in a HIV and HCV co-infected woman]. La Revue de medecine interne, 2013, Volume: 34, Issue:12 Topics: Adult; Antiviral Agents; Coinfection; Female; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Polyethylene Glycols; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Ribavirin	2013
Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World journal of gastroenterology, 2013, May-07, Volume: 19, Issue:17 Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Praziquantel; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Schistosomiasis; Schistosomicides; Time Factors; Treatment Outcome	2013
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality. Gut, 2014, Volume: 63, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Propensity Score; Recombinant Proteins; Registries; Retrospective Studies; Ribavirin; Survival Analysis; Treatment Outcome; Young Adult	2014
Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients. AIDS research and human retroviruses, 2013, Volume: 29, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Hypophosphatemia; Interferons; Kidney Diseases; Male; Middle Aged; Organophosphonates; Retrospective Studies; Ribavirin; Risk Factors; Tenofovir	2013
In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. The American journal of clinical nutrition, 2013, Volume: 98, Issue:2 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; RNA, Viral; Viral Load; Vitamin D	2013
HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy. AIDS (London, England), 2013, May-15, Volume: 27, Issue:8 Topics: Adult; Alleles; Antiviral Agents; Coinfection; Female; Follow-Up Studies; Genotyping Techniques; Hepatitis C, Chronic; Histocompatibility Antigens Class I; HIV Infections; HLA-E Antigens; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Viral Load	2013
Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection. PloS one, 2013, Volume: 8, Issue:6 Topics: Adult; Alleles; Cohort Studies; Coinfection; Female; Gene Frequency; Genetic Loci; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Immunity, Innate; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Receptors, KIR; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome	2013
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. AIDS (London, England), 2013, Nov-13, Volume: 27, Issue:17 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Interleukins; Liver Cirrhosis; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Ribavirin; Time Factors; Treatment Outcome	2013
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV medicine, 2013, Volume: 14, Issue:10 Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Therapy, Combination; Europe; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Patient Acceptance of Health Care; Poisson Distribution; Prospective Studies; Ribavirin	2013
Low rates of sustained virologic response with peginterferon plus ribavirin for chronic hepatitis C virus infection in HIV infected patients in Rio de Janeiro, Brazil. PloS one, 2013, Volume: 8, Issue:7 Topics: Adult; Aged; Antiviral Agents; Brazil; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2013
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:1 Topics: Anemia; Antiviral Agents; Coinfection; Drug Therapy, Combination; Fatigue; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Mental Health; Polyethylene Glycols; Prospective Studies; Quality of Life; Recombinant Proteins; Ribavirin; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome	2014
Treatment of patients with dual hepatitis B and C: a step in the right direction. Gut, 2014, Volume: 63, Issue:3 Topics: Antiviral Agents; Coinfection; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2014
Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection. HIV medicine, 2014, Volume: 15, Issue:2 Topics: Anemia; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Serine Proteinase Inhibitors; Viral Load	2014
IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients. AIDS (London, England), 2014, Jan-02, Volume: 28, Issue:1 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Female; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Interleukins; Male; Polymorphism, Genetic; Ribavirin; Treatment Failure	2014
Rates and predictors of response to anti-viral treatment for hepatitis C virus in HIV/HCV co-infection in a nationwide study of 619 patients. Alimentary pharmacology & therapeutics, 2013, Volume: 38, Issue:11-12 Topics: Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Erythropoietin; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2013
Vertical transmission of hepatitis C virus: a tale of multiple outcomes. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2013, Volume: 20 Topics: Antiviral Agents; Child; Coinfection; Evolution, Molecular; Female; Genetic Variation; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Pregnancy; Pregnancy Complications, Infectious; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2013
Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2014, Volume: 34, Issue:1 Topics: Animals; Coinfection; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptor, Interferon alpha-beta; Ribavirin; Signal Transduction	2014
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. HIV medicine, 2014, Volume: 15, Issue:4 Topics: Adult; Age Factors; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Disease Progression; Female; Hepatitis C; HIV Infections; Humans; Interferons; Liver Cirrhosis; Male; Prospective Studies; Retrospective Studies; Ribavirin; Risk Factors	2014
Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy. The Journal of infection, 2014, Volume: 68, Issue:4 Topics: Adult; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Time Factors; Treatment Outcome; Viral Load	2014
Hepatitis C therapy with interferon-α and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1/hepatitis C virus-coinfected patients. The Journal of infectious diseases, 2014, May-01, Volume: 209, Issue:9 Topics: Adult; Aged; Antiviral Agents; CD4-Positive T-Lymphocytes; Coinfection; DNA, Viral; Female; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Viral Load	2014
Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection. Journal of viral hepatitis, 2013, Volume: 20, Issue:12 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Elasticity Imaging Techniques; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Treatment Outcome; Viral Load	2013
[Differential response to pegylated interferon plus ribavirin combination therapy in chronic hepatitis C and HIV/HCV co-infected patients]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:11 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Polyethylene Glycols; Ribavirin; Treatment Outcome	2013
Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes. Journal of viral hepatitis, 2014, Volume: 21, Issue:3 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome; Viral Load; Young Adult	2014
A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:5 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2014
Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects. Antiviral research, 2014, Volume: 104 Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Ribavirin; Time Factors; Treatment Outcome; Viral Load; Young Adult	2014
Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment. International journal of dermatology, 2014, Volume: 53, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Coinfection; Epidermodysplasia Verruciformis; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Papillomaviridae; Ribavirin	2014
European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients. HIV medicine, 2014, Volume: 15, Issue:7 Topics: Adult; Antiviral Agents; Coinfection; DNA, Mitochondrial; Female; Genotype; Haplotypes; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Retrospective Studies; Ribavirin; Spain; White People	2014
OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients. Antiviral therapy, 2014, Volume: 19, Issue:8 Topics: Adolescent; Adult; Aged; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2014
Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV. Hepato-gastroenterology, 2013, Volume: 60, Issue:127 Topics: Antiviral Agents; Biomarkers; Coinfection; DNA, Viral; Drug Hypersensitivity Syndrome; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Guanine; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Prednisolone; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load; Virus Activation	2013
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients. BMC infectious diseases, 2014, Mar-20, Volume: 14 Topics: Adult; Aged; Antiviral Agents; Biological Availability; Coinfection; Female; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; Young Adult	2014
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes. BMC infectious diseases, 2014, Apr-23, Volume: 14 Topics: Adult; Aged; Aged, 80 and over; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C Antigens; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; RNA, Viral	2014
Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting. AIDS patient care and STDs, 2014, Volume: 28, Issue:5 Topics: Adult; Antiviral Agents; Austria; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Proline; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Young Adult	2014
HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms. HIV medicine, 2014, Volume: 15, Issue:10 Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Practice Guidelines as Topic; Ribavirin	2014
Response-guided therapy for hepatitis C genotype 2 and 3 in those with HIV coinfection. Digestive diseases and sciences, 2014, Volume: 59, Issue:8 Topics: Adult; Antiviral Agents; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Retrospective Studies; Ribavirin	2014
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. Journal of hepatology, 2014, Volume: 61, Issue:4 Topics: Adult; Aged; Antiviral Agents; beta 2-Glycoprotein I; Coinfection; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Ribavirin; Treatment Outcome; Viral Load; Virus Replication	2014
HCV viral decline at week 2 of Peg-IFN-alpha-2a/RBV therapy as a predictive tool for tailoring treatment in HIV/HCV genotype 1 co-infected patients. PloS one, 2014, Volume: 9, Issue:6 Topics: Adult; Antiviral Agents; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load	2014
Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2014, Mar-13, Volume: 20, Issue:2 Topics: Adult; Antiviral Agents; Coinfection; DNA, Viral; Egypt; Female; Genotype; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load	2014
CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals. PloS one, 2014, Volume: 9, Issue:7 Topics: Adult; Anti-HIV Agents; Cell Proliferation; Coinfection; Female; Hepatitis A Virus Cellular Receptor 2; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-7 Receptor alpha Subunit; Male; Membrane Proteins; Middle Aged; Recombinant Proteins; Ribavirin; T-Lymphocytes; Treatment Outcome	2014
Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients. PloS one, 2014, Volume: 9, Issue:7 Topics: Adult; Aged; CD4-Positive T-Lymphocytes; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Ribavirin; Tumor Necrosis Factor-alpha; Young Adult	2014
Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C. Antiviral therapy, 2015, Volume: 20, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Retrospective Studies; Ribavirin; Survival Analysis; Viral Load	2015
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study. Journal of hepatology, 2015, Volume: 62, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2015
Does HIV remain a risk factor for achieving sustained virologic response under direct acting antiviral-based modern hepatitis C virus therapy? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Dec-15, Volume: 59, Issue:12 Topics: Antiviral Agents; Coinfection; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Oligopeptides; Polyethylene Glycols; Ribavirin	2014
CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2014, Volume: 61, Issue:3 Topics: Adult; Alleles; Chemokine CXCL10; Chemokine CXCL11; Chemokine CXCL9; Coinfection; Female; Genotype; Genotyping Techniques; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Polymorphism, Genetic; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load	2014
Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2 Topics: Adult; Alleles; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Haplotypes; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-7; Male; Odds Ratio; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Retrospective Studies; Ribavirin	2015
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV. BMC infectious diseases, 2014, Volume: 14 Suppl 5 Topics: Adult; Aged; Antiviral Agents; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load	2014
Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV. International microbiology : the official journal of the Spanish Society for Microbiology, 2014, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Spain; Treatment Outcome	2014
FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients. BMC medicine, 2014, Nov-03, Volume: 12 Topics: Adult; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antiviral Agents; Body Mass Index; Coinfection; Cross-Sectional Studies; Female; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; HIV Infections; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Polymorphism, Single Nucleotide; Proteins; Ribavirin	2014
Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:5 Topics: Adult; Aged; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Middle Aged; Multivariate Analysis; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Ribavirin	2015
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. AIDS (London, England), 2015, Jan-02, Volume: 29, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppression Therapy; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load	2015
[Cost-effectiveness of hepatitis C treatment in slow virologic responders coinfected with HIV]. Cadernos de saude publica, 2013, Volume: 29 Suppl 1 Topics: Adult; Antiviral Agents; Coinfection; Cost-Benefit Analysis; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2013
Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 29 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Oligopeptides; Protease Inhibitors; Ribavirin; RNA, Viral; Viral Load	2014
Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection. Antiviral therapy, 2015, Volume: 20, Issue:4 Topics: Antiviral Agents; Coinfection; Female; Gene Expression; Genotype; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Interferons; Interleukins; Male; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2015
Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients. European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:2 Topics: Aged; Antiviral Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; Treatment Outcome; Veterans	2015
Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan. BMC infectious diseases, 2014, Dec-19, Volume: 14 Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Cohort Studies; Coinfection; Databases, Factual; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Taiwan; Tuberculosis; Young Adult	2014
Hepatitis C Virus Infection Is Systemic: Meeting Additional Goals. The Journal of infectious diseases, 2015, Aug-01, Volume: 212, Issue:3 Topics: Antiviral Agents; Coinfection; Hepatitis C, Chronic; HIV Infections; Humans; Ribavirin; Uridine Monophosphate	2015
Haemophilia-related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV-HIV coinfected man with liver failure and hepatocellular carcinoma. Haemophilia : the official journal of the World Federation of Hemophilia, 2015, Volume: 21, Issue:2 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Hemophilia A; Hepatitis C; HIV Infections; Humans; Liver Failure; Liver Transplantation; Male; Ribavirin; Sofosbuvir; Treatment Outcome; Uridine Monophosphate	2015
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:9 Topics: Anemia; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; France; Genotype; Germany; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Italy; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Oligopeptides; Proline; Ribavirin; RNA, Viral; Treatment Outcome	2015
Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women. Journal of women's health (2002), 2015, Volume: 24, Issue:2 Topics: Adult; Aging; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Glucose; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Italy; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2015
TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015, Volume: 65 Topics: Adult; Alleles; Antiviral Agents; Coinfection; Female; Genotype; Haplotypes; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Retrospective Studies; Ribavirin; Toll-Like Receptor 3	2015
Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients. AIDS (London, England), 2015, May-15, Volume: 29, Issue:8 Topics: Antiviral Agents; Coinfection; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Retrospective Studies; Ribavirin; Spain; Tertiary Care Centers	2015
Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients. PloS one, 2015, Volume: 10, Issue:3 Topics: Acute-Phase Proteins; Adult; Anti-HIV Agents; Aspartate Aminotransferases; Biomarkers; Carrier Proteins; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Kinetics; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Membrane Glycoproteins; Middle Aged; Retrospective Studies; Ribavirin; Solubility; Time Factors; Treatment Outcome	2015
High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients. Therapeutic drug monitoring, 2015, Volume: 37, Issue:6 Topics: Adult; Antiviral Agents; Chromatography, High Pressure Liquid; Cohort Studies; Coinfection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Polyethylene Glycols; Retrospective Studies; Ribavirin; Treatment Outcome	2015
A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin. Journal of medical virology, 2015, Volume: 87, Issue:10 Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Child; Cohort Studies; Coinfection; Drug Therapy, Combination; Europe; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; London; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Young Adult	2015
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy. PloS one, 2015, Volume: 10, Issue:4 Topics: Adult; Coinfection; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; Treatment Outcome	2015
Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin. PloS one, 2015, Volume: 10, Issue:5 Topics: 5' Untranslated Regions; Adult; Antiviral Agents; Base Sequence; Coinfection; Female; Genetic Variation; Hepacivirus; HIV; Humans; Interferon-alpha; Interleukins; Male; Middle Aged; Molecular Sequence Data; Polymorphism, Single-Stranded Conformational; Ribavirin; Sequence Alignment; Treatment Outcome; Young Adult	2015
HCV/HIV Coinfection: A New Treatment Paradigm. Gastroenterology, 2015, Volume: 148, Issue:7 Topics: Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Male; Ribavirin; Uridine Monophosphate	2015
Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens. AIDS patient care and STDs, 2015, Volume: 29, Issue:6 Topics: Antiviral Agents; Coinfection; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Ribavirin; RNA, Viral; Treatment Outcome	2015
Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals. AIDS patient care and STDs, 2015, Volume: 29, Issue:7 Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Protease Inhibitors; Retrospective Studies; Ribavirin; Ritonavir	2015
Successful treatment with telaprevir of post-transplant fibrosing cholestatic hepatitis C in an HIV co-infected patient. Acta gastroenterologica Latinoamericana, 2015, Volume: 45, Issue:1 Topics: Adult; Antiviral Agents; Cholestasis, Intrahepatic; Coinfection; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome	2015
Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy. European journal of clinical pharmacology, 2015, Volume: 71, Issue:8 Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Ribavirin; Simeprevir; Sofosbuvir; Substance Withdrawal Syndrome	2015
Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. Journal of viral hepatitis, 2015, Volume: 22, Issue:12 Topics: Adult; Antiviral Agents; Australia; Canada; Coinfection; Drug Therapy, Combination; Female; Germany; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interleukins; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; United States; Viral Load	2015
Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage. Therapeutic drug monitoring, 2015, Volume: 37, Issue:6 Topics: Adult; Antiviral Agents; Chromatography, High Pressure Liquid; Cohort Studies; Coinfection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Polyethylene Glycols; Retrospective Studies; Ribavirin; Time Factors	2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:9 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk; Spain; Thrombocytopenia; Treatment Outcome; Viral Load	2015
Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:10 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Ribavirin; Spain; Treatment Outcome	2015
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study. PloS one, 2015, Volume: 10, Issue:7 Topics: Adult; Antiviral Agents; Coinfection; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome	2015
Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study. BMC infectious diseases, 2015, Aug-19, Volume: 15 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Middle Aged; Odds Ratio; Personality Disorders; Polyethylene Glycols; Prisoners; Prisons; Prospective Studies; Recombinant Proteins; Ribavirin; Spain; Treatment Outcome; Young Adult	2015
Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens. Biochemistry, 2015, Sep-15, Volume: 54, Issue:36 Topics: Animals; Antiviral Agents; Benzylidene Compounds; Cell Line; Coinfection; Dogs; Dose-Response Relationship, Drug; Feasibility Studies; Fenretinide; Genes, Reporter; High-Throughput Screening Assays; Humans; Influenza A virus; Luciferases, Firefly; Luciferases, Renilla; Naltrexone; Narcotic Antagonists; Neuraminidase; Respiratory Syncytial Viruses; Ribavirin; Virus Internalization; Virus Replication; Zanamivir	2015
Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV/HCV coinfected patients. The Netherlands journal of medicine, 2015, Volume: 73, Issue:7 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Sustained Virologic Response	2015
An Hepatitis C Virus (HCV)/HIV Co-Infected Patient who Developed Severe Hepatitis during Chronic HCV Infection: Sustained Viral Response with Simeprevir Plus Peginterferon-Alpha and Ribavirin. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:17 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Simeprevir; Treatment Outcome	2015
Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response. AIDS (London, England), 2015, Sep-10, Volume: 29, Issue:14 Topics: Antiviral Agents; Coinfection; Fatal Outcome; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; RNA, Viral; Sofosbuvir; Treatment Outcome; Viral Load	2015
Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Interferon-alpha; Isoquinolines; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Pyrrolidines; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Sulfonamides; Valine	2015
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Prospective Studies; Protease Inhibitors; Ribavirin; RNA, Viral; Viral Load	2016
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:4 Topics: Adult; Antiviral Agents; Biomarkers; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome; Young Adult	2016
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome. Infection, 2016, Volume: 44, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome	2016
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients. The new microbiologica, 2015, Volume: 38, Issue:4 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polymorphism, Single Nucleotide; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2015
Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy. AIDS research and human retroviruses, 2016, Volume: 32, Issue:3 Topics: Adult; Antiviral Agents; Chemokine CXCL12; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Retrospective Studies; Ribavirin; Treatment Outcome	2016
Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report. BMC infectious diseases, 2015, Oct-29, Volume: 15 Topics: Aged; Arthritis, Rheumatoid; Coinfection; Epstein-Barr Virus Infections; Female; Hepatitis Antibodies; Hepatitis B virus; Hepatitis E; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Ribavirin	2015
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease. Journal of viral hepatitis, 2016, Volume: 23, Issue:2 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Delivery of Health Care; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Diseases; Male; Middle Aged; Patient Acceptance of Health Care; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Viral Load	2016
Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy. The Journal of infectious diseases, 2016, Mar-15, Volume: 213, Issue:6 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Biomarkers; CD4-Positive T-Lymphocytes; Coinfection; Female; Gene Expression Regulation, Viral; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2016
HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015, Volume: 73 Topics: Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; Treatment Outcome; Viral Load	2015
Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord. BMC infectious diseases, 2015, Nov-04, Volume: 15 Topics: Adult; Anti-HIV Agents; Cohort Studies; Coinfection; Dideoxynucleosides; Drug Combinations; Emtricitabine; Europe; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin; Tenofovir; Zidovudine	2015
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study. Scientific reports, 2015, Nov-30, Volume: 5 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Male; Middle Aged; Odds Ratio; Prospective Studies; Ribavirin; Taiwan; Treatment Outcome; Viral Load	2015
Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:18 Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Coinfection; Cyclopropanes; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Proline; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine	2015
Interleukin-2 receptor antagonist immunosuppression and consecutive viral management in living-donor liver transplantation for human immunodeficiency virus/hepatitis C-co-infected patients: a report of 2 cases. Clinical journal of gastroenterology, 2016, Volume: 9, Issue:1 Topics: Antiviral Agents; Coinfection; Combined Modality Therapy; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Receptors, Interleukin-2; Recombinant Proteins; Ribavirin	2016
Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Apr-01, Volume: 62, Issue:7 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Ribavirin; Treatment Outcome	2016
Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era? AIDS patient care and STDs, 2016, Volume: 30, Issue:2 Topics: Adult; Aged; Ambulatory Care Facilities; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Odds Ratio; Retrospective Studies; Ribavirin; Treatment Outcome; United States	2016
IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:9 Topics: Adult; Antiviral Agents; Biomarkers; Coinfection; Cross-Sectional Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukin-15; Interleukins; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Retrospective Studies; Ribavirin; Spain; Sustained Virologic Response; Viral Load	2016
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy. The pharmacogenomics journal, 2017, Volume: 17, Issue:4 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Platelet Count; Receptors, KIR; Ribavirin; Thrombocytopenia	2017
Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection. The Journal of infectious diseases, 2016, 07-01, Volume: 214, Issue:1 Topics: Adult; Antiviral Agents; Canada; Cohort Studies; Coinfection; Female; Genotype; Hepatitis C; HIV Infections; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Ribavirin	2016
Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study. Medicine, 2016, Volume: 95, Issue:11 Topics: Adult; Age Factors; Alkynes; Atazanavir Sulfate; Benzoxazines; CD4-CD8 Ratio; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Interferon Type I; Male; Middle Aged; Oligopeptides; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Ribavirin; Ritonavir	2016
Double Filtration Plasmapheresis in Treatment of Patients With Co-Infection of Hepatitis C and Human Immunodeficiency Virus. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:4 Topics: Adult; Antiviral Agents; Coinfection; Combined Modality Therapy; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Plasmapheresis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2016
Matrine displayed antiviral activity in porcine alveolar macrophages co-infected by porcine reproductive and respiratory syndrome virus and porcine circovirus type 2. Scientific reports, 2016, Apr-15, Volume: 6 Topics: Alkaloids; Animals; Antiviral Agents; Cells, Cultured; Circovirus; Coinfection; Cytopathogenic Effect, Viral; Enzyme Activation; Gene Expression; Gene Expression Regulation, Viral; Genes, Viral; Macrophages, Alveolar; Matrines; NF-kappa B; Porcine respiratory and reproductive syndrome virus; Quinolizines; Ribavirin; Swine; Toll-Like Receptor 3; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Virus Replication	2016
[Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016, Mar-20, Volume: 24, Issue:3 Topics: Anti-Retroviral Agents; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunotherapy; Interferon-alpha; Male; Prospective Studies; Recurrence; Ribavirin; RNA, Viral; Standard of Care; Sustained Virologic Response; Treatment Outcome; Viral Load	2016
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy. Alimentary pharmacology & therapeutics, 2016, Volume: 43, Issue:12 Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Transplant Recipients; Treatment Outcome; Valine	2016
INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA. Georgian medical news, 2016, Issue:252 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Georgia (Republic); Hepatitis C; HIV Infections; Humans; Incidence; Interferon-alpha; Male; Polyethylene Glycols; Retrospective Studies; Ribavirin; Tuberculosis, Pulmonary	2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS (London, England), 2016, 08-24, Volume: 30, Issue:13 Topics: Anemia; Antiviral Agents; Coinfection; Decision Support Techniques; Drug Therapy, Combination; Female; Genotyping Techniques; Glomerular Filtration Rate; Hepatitis C, Chronic; HIV Infections; Humans; Male; Membrane Transport Proteins; Oligopeptides; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Proline; Ribavirin	2016
Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:9 Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Fatigue; Female; France; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Linear Models; Male; Middle Aged; Multivariate Analysis; Recovery of Function; Ribavirin; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome; Viral Load	2016
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 08-15, Volume: 63, Issue:4 Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Middle Aged; Recurrence; Ribavirin; Salvage Therapy; Sofosbuvir; Treatment Failure	2016
Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials. Antiviral therapy, 2017, Volume: 22, Issue:4 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Prognosis; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Sofosbuvir; Treatment Failure; Uridine Monophosphate	2017
Treatment of Hepatitis C Virus in HIV-Coinfected Individuals in Real-world Clinical Settings: Results From 2 Large HIV Care Clinics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 10-01, Volume: 63, Issue:7 Topics: Antiviral Agents; Coinfection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Ribavirin	2016
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 49 Topics: Antiviral Agents; Carbamates; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Valine	2016
From current status to optimization of HCV treatment: Recommendations from an expert panel. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Italy; Liver Cirrhosis; Liver Neoplasms; Practice Guidelines as Topic; Ribavirin; Societies, Medical; Viral Load	2016
IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:11 Topics: Adult; Antiviral Agents; Coinfection; Female; Hepatitis C; HIV Infections; Humans; Liver Transplantation; Male; Middle Aged; Ribavirin; Sofosbuvir; Sustained Virologic Response; Transplant Recipients; Treatment Outcome	2016
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study. Medicine, 2016, Volume: 95, Issue:29 Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Disease Progression; Female; Hepatitis C; HIV Infections; Humans; Incidence; Interferons; Kaplan-Meier Estimate; Liver Cirrhosis; Longitudinal Studies; Male; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome	2016
Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients. Journal of infection in developing countries, 2016, Aug-02, Volume: 10, Issue:7 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Sustained Virologic Response; Treatment Outcome	2016
Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease. Antiviral therapy, 2017, Volume: 22, Issue:3 Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Liver Diseases; Liver Function Tests; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine; Viral Load	2017
Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong. Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:6 Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Hong Kong; Lactams, Macrocyclic; Liver Cirrhosis; Liver Transplantation; Macrocyclic Compounds; Proline; Retrospective Studies; Ribavirin; Ritonavir; Sulfonamides; Time Factors; Treatment Outcome; Uracil; Valine	2017
Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin. Journal of neurovirology, 2017, Volume: 23, Issue:2 Topics: Adult; Aged; Antiviral Agents; Cognitive Dysfunction; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin	2017
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? AIDS (London, England), 2017, 03-13, Volume: 31, Issue:5 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Europe; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Mortality; Prognosis; Ribavirin; RNA, Viral; Survival Analysis; Sustained Virologic Response; Treatment Outcome; Viral Load	2017
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology (Baltimore, Md.), 2017, Volume: 66, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Coinfection; Comorbidity; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Regression Analysis; Retrospective Studies; Ribavirin; Risk Assessment; Spain; Survival Analysis; Time Factors; Treatment Outcome	2017
Sofosbuvir in the treatment of early HCV infection in HIV-infected men. HIV clinical trials, 2017, Volume: 18, Issue:2 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Interleukins; Male; Middle Aged; Mutation; Pilot Projects; Ribavirin; Sofosbuvir; Time Factors; Treatment Outcome; Viral Load	2017
Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-15, Volume: 64, Issue:12 Topics: Administration, Oral; Aged; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cohort Studies; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Practice Patterns, Physicians'; Proline; Registries; Ribavirin; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate; Valine; Veterans	2017
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort. Journal of acquired immune deficiency syndromes (1999), 2017, 05-01, Volume: 75, Issue:1 Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; France; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine	2017
[Biliary and kidney lithiasis during treatment with daclatasvir/sofosbuvir/ribavirin and atazanavir/ritonavir + abacavir/lamivudine in an HIV/HCV genotype 4-infected patient: a case report.] Recenti progressi in medicina, 2017, Volume: 108, Issue:2 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; Biliary Tract Diseases; Carbamates; Coinfection; Dideoxynucleosides; Drug Combinations; Drug Interactions; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Kidney Calculi; Lamivudine; Lithiasis; Male; Pyrrolidines; Ribavirin; Ritonavir; Sofosbuvir; Valine	2017
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. Journal of viral hepatitis, 2011, Volume: 18, Issue:7 Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Female; Flaviviridae Infections; GB virus C; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome	2011
Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Addiction (Abingdon, England), 2012, Volume: 107, Issue:1 Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Ethanol; Female; France; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Medication Adherence; Middle Aged; Prospective Studies; Ribavirin; Socioeconomic Factors; Substance Abuse, Intravenous; Surveys and Questionnaires	2012
[Coinfection with HIV and HCV: abacavir and ribavirine, why not?]. Revista clinica espanola, 2012, Volume: 212, Issue:1 Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Dideoxynucleosides; Drug Combinations; Drug Interactions; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Ribavirin; Zidovudine	2012
Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. Journal of hepatology, 2012, Volume: 56, Issue:3 Topics: Adult; Antiviral Agents; Coffee; Coinfection; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Surveys and Questionnaires	2012
Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? Expert review of anti-infective therapy, 2011, Volume: 9, Issue:9 Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; Coinfection; Drug Interactions; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Oligopeptides; Proline; Ribavirin; Serine Proteases; Serine Proteinase Inhibitors; Viral Proteins	2011
High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic. International journal of STD & AIDS, 2011, Volume: 22, Issue:10 Topics: Adult; Ambulatory Care Facilities; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Program Evaluation; Recombinant Proteins; Referral and Consultation; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2011
Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy. Antiviral research, 2012, Volume: 93, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coinfection; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferons; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Ribavirin; Risk Factors; Young Adult	2012
Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient. Virology journal, 2011, Nov-14, Volume: 8 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load; Virus Activation; Young Adult	2011
IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients. European journal of clinical investigation, 2012, Volume: 42, Issue:6 Topics: Adult; Antiviral Agents; Chemokine CXCL10; Coinfection; Female; Genotype; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Models, Biological; Polyethylene Glycols; Polymorphism, Single Nucleotide; Predictive Value of Tests; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2012
Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients. Antiviral therapy, 2011, Volume: 16, Issue:8 Topics: Adult; Antiviral Agents; Cell Line; Cohort Studies; Coinfection; Female; Hepacivirus; Hepatic Stellate Cells; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Ireland; Lopinavir; Male; Monocytes; Recombinant Proteins; Ribavirin; RNA, Viral; Saquinavir; Tissue Inhibitor of Metalloproteinase-2; United Kingdom; Viral Load	2011
Relative impact of ribavirin monitoring and HIV coinfection on sustained virological response in patients with chronic hepatitis C. Antiviral therapy, 2011, Volume: 16, Issue:8 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Coinfection; Drug Monitoring; Drug Therapy, Combination; Female; France; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Virus Replication	2011
Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. AIDS research and human retroviruses, 2012, Volume: 28, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2012
The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection. Viral immunology, 2012, Volume: 25, Issue:2 Topics: Adult; Anti-HIV Agents; Antigens, CD; Antiviral Agents; Apoptosis; CD4 Lymphocyte Count; Coinfection; Female; Flow Cytometry; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Neutrophil Activation; Neutrophils; Reactive Oxygen Species; Ribavirin; Viral Load	2012
Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients. PloS one, 2012, Volume: 7, Issue:2 Topics: Adult; Bacteria; Biomarkers; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coinfection; Demography; Female; Fibrosis; Hepatitis C, Chronic; HIV Infections; HLA-DR Antigens; Humans; Interferon-alpha; Lipopolysaccharide Receptors; Lipopolysaccharides; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Solubility; Treatment Outcome	2012
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection. AIDS (London, England), 2012, Aug-24, Volume: 26, Issue:13 Topics: Adult; Antiviral Agents; Australia; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Seropositivity; Humans; Interferon-alpha; Interferons; Interleukins; Logistic Models; Male; Polymorphism, Single Nucleotide; Prospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2012
Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response. Journal of viral hepatitis, 2012, Volume: 19, Issue:6 Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Male; Middle Aged; Prospective Studies; Ribavirin	2012
ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV. Journal of medical virology, 2012, Volume: 84, Issue:7 Topics: Adult; Anemia; Antiviral Agents; Coinfection; Female; Genotype; Hemoglobins; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Male; Middle Aged; Pilot Projects; Polymorphism, Single Nucleotide; Prospective Studies; Pyrophosphatases; Ribavirin; Treatment Outcome	2012
Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy. Journal of gastroenterology, 2012, Volume: 47, Issue:12 Topics: Adult; Amino Acid Sequence; Antiviral Agents; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunity, Cellular; Interferon alpha-2; Interferon-alpha; Interferon-gamma; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2012
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:5 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Female; Hepatitis C; HIV Infections; Humans; Interferons; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Ribavirin; Spain; Treatment Outcome; Viral Load	2012
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients. AIDS (London, England), 2012, Aug-24, Volume: 26, Issue:13 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2012
New approaches to the management of hepatitis C in haemophilia in 2012. Haemophilia : the official journal of the World Federation of Hemophilia, 2012, Volume: 18 Suppl 4 Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2012
Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2012, Volume: 55, Issue:1 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Ribavirin	2012
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? AIDS (London, England), 2012, Nov-13, Volume: 26, Issue:17 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Dideoxynucleosides; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Ribavirin; RNA, Viral; Surveys and Questionnaires; Treatment Outcome; Viral Load	2012
Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients. AIDS and behavior, 2013, Volume: 17, Issue:1 Topics: Adult; Aged; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Socioeconomic Factors; Treatment Outcome; Young Adult	2013
Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin. Acta biochimica Polonica, 2012, Volume: 59, Issue:3 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Genotyping Techniques; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Young Adult	2012
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin. Antiviral therapy, 2012, Volume: 17, Issue:7 Topics: Adult; Anti-Retroviral Agents; Cardiac Output; CD4 Lymphocyte Count; Coinfection; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Hypertension, Portal; Hypertension, Pulmonary; Interferon-alpha; Liver; Liver Cirrhosis; Lung; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prospective Studies; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Treatment Outcome; Viremia	2012
Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patients. AIDS (London, England), 2012, Sep-24, Volume: 26, Issue:15 Topics: Acquired Immunodeficiency Syndrome; Alleles; Anti-HIV Agents; Antiviral Agents; Chromosomes, Human, Pair 6; Coinfection; Female; Genotype; Hepatitis C, Chronic; HIV-1; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Failure	2012
Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance. European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:2 Topics: Adult; Antiviral Agents; Biomarkers; Carrier State; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Portugal; Prospective Studies; Ribavirin; Viral Load	2013
The effect of unsuccessful treatment with peginterferon and ribavirin on the liver fibrosis course of HIV/HCV-coinfected patients. Current HIV research, 2012, Volume: 10, Issue:8 Topics: Adult; Antiviral Agents; Coinfection; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Failure	2012
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV. Infection, 2013, Volume: 41, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; Treatment Outcome; Viral Load	2013
Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients. AIDS (London, England), 2013, Jan-14, Volume: 27, Issue:2 Topics: Adult; Alleles; Antiviral Agents; Coinfection; Cytokines; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Viral Load	2013
Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients. AIDS (London, England), 2013, Mar-13, Volume: 27, Issue:5 Topics: Adult; Alleles; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Gene Expression Regulation; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Spain; Treatment Outcome; Viral Load	2013
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS (London, England), 2013, Jan-14, Volume: 27, Issue:2 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Vitamin D; Vitamin D Deficiency	2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome; Viral Core Proteins	2013
HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism. Journal of viral hepatitis, 2013, Volume: 20, Issue:3 Topics: Adult; Aged; Antiviral Agents; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Interleukins; Male; Middle Aged; Polymorphism, Genetic; Ribavirin; RNA, Viral; Standard of Care; Treatment Outcome; Viral Load; Young Adult	2013
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus. Journal of hepatology, 2013, Volume: 58, Issue:6 Topics: Adult; Alanine Transaminase; Cohort Studies; Coinfection; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Male; Proportional Hazards Models; Ribavirin	2013